NMDE Flashcards

1
Q

Epidemiology UC

A
2-10 per 100,000
Increased in females
Increased in Caucasians
Bimodal peaks 15-25 and 55-65
FHx component 

Decreased in smokers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Symptoms & signs of UC

A
relapsing and remitting in nature
Diarrhoea
PR bleeding
Frequency of stools, associated with urgency
Fatigue and malaise
Fever
Mucus discharge

Tachycardia
Fever
Abdominal tenderness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Disease features of UC

A
Only affects the colon, always affects the rectum
Inflammation limited to the mucosa
Mucosal atrophy, walls appear thin
Ulcers are superficial with a broad base
No skin lesions
No mural thickening, no strictures, no fistulas
No malabsorption 
Malignant potential
No recurrence post-op
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of UC

A

Defects in host interaction with intestinal bacteria
Intestinal epithelial dysfunction
Inappropriate mucosal immune responses

TH17 and TH2 are increasingly active

Defects in epithelial tight junctions increased passage of bacteria to cause a reaction
Increased cytokine activity

No specific gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Investigations for UC

A

FBC - anaemia or thrombocytosis
LFTs - raised ALP, hypoalbuminaemia, hypokalaemia, hypomagnesaemia
Raised ESR and CRP
Test iron, B12, folate

Foetal calprotectin, usually used for monitoring.
Stool samples for infection,

ANCA positive

Colonoscopy/sigmoidoscopy + biopsy - abnormal erythematous mucosa with ulceration - biopsy for confirmation

Abdominal X-ray to check for perforation.
Double contrast barium enema - lead piping

Foetal calprotectin, usually used for monitoring

Can use CT enterography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Measuring severity of UC

A

Using Truelove & Witt’s severity index

MILD - diarrhoea <4 times /day, no anaemia, no fever, no tachycardia, no weight loss

MODERATE - diarrhoea 4/5 times per day, Small amount of blood in stool, no fever, no tachycardia, raised CRP (mild)

SEVERE - diarrhoea 6+ times a day, blood in stool, fever, tachycardia, anaemia, raised CRP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Extracolonic manifestations of UC

A
Uveitis
Pleuritis
Erythema nodosum
Ankylosing spondylitis
Pyoderma gangrenosum

Primary sclerosing cholangitis
MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management of UC - inducing remission

A
  1. Amniosalicylates - mesalazine
  2. Corticosteroids - oral prednisolone
  3. Immunomodulators - azathioprine, methotrexate, ciclosporin
  4. Mabs - Infliximab in severe cases
  5. Surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Complications of UC

A

Bleeding
Toxic megacolon
Increased risk of colon cancer

Perforation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Epidemiology of Crohn’s

A
1-6 per 100,000
Increased in females
Increased in Caucasians
Bimodal age peak 15-25 and 55-65
Genetic link - NOD2

Smoking is a big risk factor
Most common in ileocaecal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Symptoms of Crohn’s

A
Diarrhoea
PR bleeding
Abdominal pain
Weight loss
Fatigue
Mouth ulcers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Features of Crohn’s

A
Any part of GI tract
Transmural, can form strictures
Skip lesions
Oedema and loss of mucosal texture
Triggered by emotional stresses or smoking
Cobblestone appearance
Ulcers deep and knife like
Fistulas common
Fat/vitamin malabsorption
Malignant potential if in colon
Recurrence post-op is common

40% ileocecal, 30% small intestine, 25% colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pathophysiology of Crohn’

A

Defects in host interaction with intestinal bacteria
Intestinal epithelial dysfunction
Inappropriate mucosal immune responses

TH17 and TH2 are increasingly active

Defects in epithelial tight junctions increased passage of bacteria to cause a reaction
Increased cytokine activity

NOD 2 gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Investigations in Crohn’s

A

FBC - anaemia
Raised CRP
Nutrient deficiency, B12, folate
LFTs hypoalbuminaemia

Stool culture for C.diff
ASCA (not ANCA as in UC)

Endoscopy - ileocolonoscopy + biopsies, occasionally OGD

Abdominal X-ray for perforation

Small bowel follow through - cobblestone appearance

Can have CT enterography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of Crohn’s - inducing remission

A
  1. Steroid - prednisolone
  2. Aminosallicylate - mesalazine
  3. Azathioprine / mercaptopurine
  4. Methotrexate
  5. Infiximab or adalimumab

Surgery is last line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of Crohn’s - maintenance

A

Azathioprine or mercaptopurine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Extraintestinal features of Crohn’s

A
Uveitis
Migrating polyarthritis
Ankylosing spondylitis
Clubbing
Pyoderma gangrenosum (greater incidence than in UC)
Erythema nodosum
Aphthous ulcers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Classification of Crohn’s disease

A

Crohn’s disease activity index
<150 remission, 150-300 active, 300+ severe
Depends on number of stools, pain, well being, extra intestinal manifestations, pyrexia, etc.

Harvey Bradshaw Index
<4 = remission, 5-8 moderate, 8+ severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Complications of Crohn’s

A
Small bowel obstruction
Perianatal fistula/fissure
bowel fistula
Bowel perforation
GI blood loss
Cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Causes of upper GI bleeding

A

Gastritis - dyspepsia

Oesophagitis - dyspepsia , worse on lying

Gastric/duodenal ulcer - nausea, vomiting, weight loss, dyspepsia

Oesophageal/gastric varices - Hx of liver disease, alcohol excess

Cancer - malaise, weight loss, vomiting, early satiety

Mallory-Weiss tear = young, history of vomiting, small amounts

Gastric/duodenal erosions = NSAID or alcohol history, epigastric pain

Drugs = aspirin, NSAIDs, steroidsm thrombolytics, anticoagulants

Rare = bleeding disorders, aorto-enteric fistula, Meckel’s diverticulum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Symptoms and Signs of upper GI bleeding

A

Fresh haematemesis or coffee grounds
Melaena
Medication and alcohol history

Tachycardic and hypotensive
Cap refill may be reduced
Postural BP drop
Anaemia - pallor

Stigmata of liver disease - hepatic flap, caput medusa, ascites, hepatomegaly, spider naevi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Investigations for GI bleeding

A

FBC - haemoglobin and MCV (if low MCV, may be chronic)
U&E - raised urea to creatinine ratio
LFTs - clotting and signs of chronic liver disease

Upper GI endoscopy - NBM for 4 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Classification of GI bleeds

A

Rockall risk scoring
- relies on BP, HR, endoscopy
Low risk - 0-1, moderate 2-3, severe 4+

Blatchford score
No endoscopy required
Predicts who needs intervention - 6+ needs intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Management of upper GI bleed

A

Non-variceal

  • Resuscitate
  • Endoscopy within 4/24 hours, urgent/non-urgent, no routine PPI pre-endoscopy

Variceal

  • Resuscitate
  • Terlipressin
  • Variceal band, ligation/adrenaline injections/ TIPS/ glue
  • Balloon tamponade - Sengstaken-Blakemore tube
  • antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Side effects of blood transfusions
Hypothermia as products stored at fridge temperature Hypocalcaemia - blood contains citrate which chelates calcium Hyperkalaemia
26
Causes of lower GI bleeding visible
``` Haemorrhoids Fissures Carcinoma Polyps Proctitis Diverticular disease IBD Angiodysplasia Infection - E.coli, shigella, salmonella, campylobacter ```
27
Investigations for lower GI bleeding visible
``` FBC U&Es Clotting LFTs Colonoscopy or flexi sig Rectal exam Stool cultures ```
28
Causes of occult GI bleeding
``` Coeliac disease Gastric cancer Peptic ulcer disease Colorectal cancer IBD ```
29
Management of occult GI bleeding
Treat underlying cause Replace iron stores if deficient Check blood count after 1 month to see if it improves
30
Signs, symptoms and deficiency states for fat soluble vitamins
A - Night blindness D - Osteomalacia - Proximal limb weakness E - Anaemia K - Clotting deficiency - Bruising
31
Signs, symptoms and deficiency state for vitamins B6, B12, C and folate
B6 - Dermtitis, anaemia B12 - Pernicious anaemis - Tired/fatigue/pale/peripheral neuropathy Folate - megaloblastic anaemia - tired.fatigue.pale C - Scurvy - bruising, gingivitis
32
Reasons for malnutrition in hospitals
Secondary to pathological disease - raised metabolic demand Neglect - by patient or staff NBM
33
Who should receive nutritional support in hospitals
Consider in all - BMI < 18.5 - Unintentional weight loss >10% in 3-6 months - BMI < 20 and unintentional weight loss >5% in 3-6 months - Eaten little or nothing for 5 days and not likely to in next 5 days - Poor absorptive capacity
34
Methods of enteral feeding
Oral - supplementation e.g, fortisips Tube feeding - NG tube if inadequate or unsafe oral intake Enterostomy feeding - if for over 4-6 weeks PEG tube - can get perforation, infection or peritonitis
35
Parenteral feeding
- Only if other routes not suitable e.g. perforated GI tract If short term can use peripheral cannula <14 days If not the PICC line Complicated by thrombophlebitis
36
Refeeding syndrome
Complication from too rapid reintroduction of feeding following starvation. Low insulin levels secondary to starving. When feeding restarted, increased insulin. Insulin causes cellular uptake of phosphate Low phosphate causes respiratory/cardiac failure, muscle weakness, seizures, coma usually occurs in day 4 of refeeding
37
Which patients are at high risk of refeeding syndrome
BMI < 16 History of alcohol abuse Little or no intake for 10 days Low levels of phosphate, potassium or magnesium prior to feed Unintentional weight loss of >15% in last 3-6 months
38
Clinical features of malabsorption
``` Diarrhoea Steatorrhoea Weight loss Fatigue Flatulence and abdominal distension Oedema from hypoalbuminaemia Bleeding disorders (vit K) Metabolic defects in bones Neurological manifestation (low Ca, Mg - tetany) ``` ``` Orthostatic hypotension Decreased subcut fat Signs of muscle loss or wasting Hyperactive bowel sounds Ascites Pallor Peripheral oedema Glossitis ```
39
Causes of hypochromic microcytic anaemia
Iron deficiency anaemia - blood loss, increased demand (growth and pregnancy), decreased absorption (post-gastrectomy, Crohn's), poor intake Thalassaemia Anaemia of chronic disease Sideroblastic anaemia
40
Causes of normocytic normochromic anaemia
``` Acute blood loss CKD Anaemia of chronic disase Autoimmune rheumatic disease Endocrine disease Marrow infiltration Haemolytic anaemia ```
41
Causes of macrocytic anaemia (megaloblastic)
Vitamin B12 or folate deficiency B12 - gastrectomy, ileal disease, resection Folate - alcohol, coealiac, Crohn's, partial gastrectomy, cancer, drugs
42
Clinical features of anaemia
``` Fatigue headache angina, breathlessness pallor palpitations tachycardia ```
43
Epidemiology of coeliac disease
Increased in females (2 to 1) Age peaks in early childhood and again 40-50 1-2% prevalence FHx - HLA DQ2 RF - other autoimmune disease
44
Signs and symptoms of coeliac disease
``` Tiredness, malaise GI symptoms may be absent or mild Diarrhoea or steatorrhoea Abdominal pain diffuse Weight loss ``` Mouth ulcers Angular stomitis Anaemia/pallor Dermatitis herpetiformis
45
Subgroups of coeliac disease
Classic - 50% Typical symptoms Atypical Lacks GI symptoms but presents with deficiency state or extra intestinal features Silent - 20% No signs of symptoms Non-responsive Refractory - 1%
46
Pathophysiology of coeliac disease
Proteins in wheat, barley, rye are broken down by tissue transglutaminase into GLIADIN Gliadin then presents to T cells via HLA class 2 DQ2 and DQ8 T cells produce inflammatory cytokines Over expression of IL 15
47
Investigations for coeliac disease
IgA anti-tissue transglutaminase antibodies - highly specific and sensitive. They become undetectable after 6 months of a gluten free diet FBC - microcytic anaemia from iron deficiency Howell-Jollie bodies (leukocytes) LFTs - raised transaminases Small bowel biopsy is gold standard - need to still be consuming gluten
48
Treatment of coeliac disease
GLUTEN FREE DIET! NHS can subsidise gluten free products Recommended to have 5 yearly pneumococcal vaccinations
49
Hernias - most to least common
``` Inguinal (indirect or direct) Femoral Umbilical and parumbilical Incisional Ventral and epigastric ```
50
Types of hernias: | reducible/irreducible/strangulation
Reducible - contents replaced completely back into peritoneal cavity Lump disappears lying down, not painful Cough impulse ``` Irreducible Adhesions to sac wall mass larger than neck not reducible Cough impulse ``` Strangulation Contents restricted by neck so circulation is cut off - gangrene inevitable Severe pain, central, colicky vomiting, distension, constipation (from obstruction) Tender,tense No cough impulse Noisy bowel sounds
51
Hernias most likely to strangulate
1. Femoral 2. Indirect inguinal 3. Umbilical
52
Indirect inguinal hernia
``` Pass through internal ring Lateral to inferior epigastric vessels May be congenital Can be controlled by pressure over internal ring Commonly strangulates due to narrow neck Often extends to scrotum Does not readily reduce on lying ``` Hernia does not reach full size until the patient has been up for some time, does not reduce on lying
53
Direct inguinal hernia
Pass through posterior wall of inguinal canal MEDIAL to inferior epigastric vessels Always acquired Not controlled by pressure over internal ring Rarely strangulate due to wide neck Reduces spontaneous on lying
54
Borders of the inguinal canal
Anterior - skin, external oblique aponeurosis Posterior - conjoint tendon forms posterior well medially, transversalis fascia laterally Above - internal oblique and transversus abdominis Below - inguinal ligament
55
Describe a femoral hernia
passes through the femoral canal Medial to the femoral sheath Femoral sheath contains the femoral artery and vein ``` Occurs more commonly in women Usually seen in elderly and middle aged Non-strangulated swelling, BELOW and LATERAL to pubic tubercle Enlarges on standing and coughing Disappears on lying down ``` STRAGULATION COMMON due to narrow neck`
56
Exomphalos
Rare condition | Failure of all or part of midgut to return to abdominal cavity in foetal life
57
Presentation of congenital diaphragmatic hernias
Different types In more serious cases - present as respiratory distress shortly after birth and require urgent surgery Others e.g. large oesophageal hiatus = present as regurgitation, vomiting, dysphagia and progressive weight loss in the child
58
Types of acquired hiatus hernia
Sliding (90%) stomach slides through hiatus and is covered anteriorly with peritoneal sac, posterior = extraperitoneal. It disturbs cardio-oesophageal mechanism and produces the effect of a space occupying lesion Rolling (10%) Cardia remains in position, stomach rolls up anteriorly through volvulus - partial volvulus. No symptoms of regurgitation. Represents progressive weakening of hiatus muscles. Occur in obese, middle aged and elderly. 4x more common in women
59
Presentation of acquired hiatus hernia
``` cough dyspnoea palpitations hiccough burning retrosternal pain worse on lying and swooping occult bleeding from oesophagitis ```
60
Treatment of hiatus hernia
Treat symptomatically | If not controlled then laparoscopic repair
61
Epidemiology of colon cancer
``` 50 per 100,000 3rd most common malignancy Increases with age More common in men FHx is associated especially regarding HNPCC, FAP ``` ``` RFs UC or Crohn's Pelvic radiotherapy Smoking Alcohol Obesity Sedentary lifestyle High red meat in diet Type 2 diabetes aspirin/NSAIDs Cholecystectomy Low fibre diet ```
62
Signs and symptoms of colon cancer
Dependent on site of cancer Left - fresh rectal bleeding, early obstruction, tenesmus, mucus (if rectal), early change in bowel habit, mass in LIF Right - anaemia from occult bleeding, altered bowel habit (alternating diarrhoea and constipation), mass in RIF ``` Colicky pain Weight loss Can present with obstruction or perforation SOB/fatigue (from anaemia) Hepatomegaly/ascites if mets Signs of peritonitis ```
63
Signs of peritonitis
Rock hard abdomen rebound tenderness absent bowel sounds
64
most common places for bowel cancer
45% rectosigmoid 30% ascending colon 15% descending colon 10% transverse colon
65
Pathophysiology of colon cancer
Malignant transformation of benign adenomatous polyp Accumulation of multiple genetic mutations APC gene K-ras gene - failure leads to cell proliferation DCC gene - has a role in invasion and metastasis p533 gene - role in impaired apoptosis and cell proliferation
66
HNPCC
Hereditary non-polyposis colon carcinoma Also known as Lynch syndrome Occurs at a young age with family history - autosomal dominant Mean age 45, lifetime risk 80% It is the most hereditary syndrome Majority occur proximally Increased risk of other cancers: endometrium, ovary, urinary tract, stomach, small intestine, pancreas, CNS Regular colonoscopy every 1-2 years from 25 Criteria for diagnosis - 3+ relatives with colon cancer (1 must be 1st degree, must be across 2 generations) & 1 family member affected under 50, FAP excluded
67
FAP
Familial adenomatous polyposis Hereditary disorder causing numerous polyps and resulting in colon carcinoma before 40 Autosomal dominant Patients usually asymptomatic Diagnosis by colonoscopy (100+ polylps) and genetic testing (APC gene) Treated with colectomy Polyps present in 50% by 15 and 95% by 35 Extra intestinal manifestations: - osteoma of skull/mandible - sebaceous cysts - increase in cancer: small intestine, pancreas, thyroid, brain, liver and gastric cancer
68
Treatment of colon cancer
surgery - without metastatic disease. Tumour + resection margins+ pericolic lymph nodes removed May reanastamose or stoma Adjuvant therapy = if lymph spread it can't be controlled with surgery alone Chemotherapy with 5-FU or carbecitabine or irinotecan
69
Investigations for colon cancer
FBC - anaemia LFTs - for mets Colonoscopy for diagnosis + biopsy (GOLD STANDARD) CT colongraphy CT or MRI and liver US for staging PET for recurrent but not initial cancer CEA is raised in colon cancer but is not useful for screening. Good prognostic factor, better outcome if CEA negative,
70
Screening for colon cancer
Faecal occult blood | Every 2 years after 60
71
When to refer for suspected bowel cancer?
>40 + rectal bleeding + loose stools for over 6 weeks >60 with rectal bleeding OR loose stools >6 weeks regardless of other symptoms If right lower abdominal mass consistent with large bowel Palpable rectal mass (NOT pelvic - urology or gynae referral) Men with unexplained iron deficiency anaemia <11 Non-menstruating women with unexplained iron deficiency anaemia <10
72
Staging for bowel cancer
``` Dukes A - tumour confined to bowel (10%) B - extension through bowel wall (35%) C - tumour involving lymph nodes (30%) D - distant mets (25%) ``` Or can use TNM T - 1 submuscosa, 2 muscularis propria, 3 pericolorectal tissues, 4A surface of visceral peritoneum, 4B directly invades
73
Symptoms of peritonitis
``` Abdominal pain ** Localised pain if contained, generalised after rupture Anorexia Nausea Vomiting Fever and chills Diarrhoea ```
74
Signs of peritonitis
High fever in early stages Rebound tenderness Absent bowel sounds Rock hard abdomen Guarding and rigid abdomen Hypotensive Signs of septic shock DRE increases abdominal pain
75
Aetiology of primary peritonitis
Spontaneous bacterial peritonitis is acute bacterial of infection of ascitgic fluid resulting from translocation ofbacteria across gut wall Complications of ascites 90% is mono-microbial 40% E.coli, 7% Klebsiella pneumonia, 15% strep 30% Predominantly gram negative
76
Aetiology of secondary peritonitis
Pathogens depend on location in GI tract Mainly gram positive in upper HI tract Colon perforation generally multi-microbial and predominantly gram negative All caused by perforation
77
Causes of peritonitis
``` Malignancy Penetrating trauma Ulcer perforation Stone perforation Iscahemic bowel Bowel obstruction Crohn's Appendicitis Post-operative Peritoneal dialysis Pancreatitis ```
78
Investigations for peritonitis
FBC - raised WBC, CRP LFTs, amylase and lipase for pancreatitis Blood cultures - sepsis Peritoneal fluid for culture Urinalysis to rule out urinary tract pathology Abdominal x=ray CT/MRI
79
Treatment for peritonitis
Correction of underlying pathology Systemic antibiotics Supportive therapy to prevent organ system failure Antibiotics are dependent on the cause - usually 3rd generation cephalosporin Haemodynamic, pulmonary and renal support = fluid resuscitation, monitor renal function, blood gases, urine output, BP, HR Nutrition support - high requirement in sepsis Surgery to correct pathology
80
Describe pain coming from fore, mid and hindgut
Foregut = stomach, duodenum, liver, pancreas. Pain described as upper abdominal pain. Midgut = small bowel, proximal colon and appendix. Pain felt in umbilicus Hindgut = distal colon and genito-urinary tract. Lower abdominal pain
81
Causes of diffuse abdominal pain
``` Pancreatitis Diabetic ketoacidosis Early appendicitis Gastroenteritis Intestinal obstruction Mesenteric ischaemia Peritonitis Sickle cell anaemia crisis Spontaneous bacteria peritonitis Typhoid fever ```
82
Red flags for abdominal pain
``` Severe pain Tachycardia Hypotension Confusion Signs of peritonitis Abdominal distension ```
83
Causes of RUQ pain
``` Appedicitis with gravid uterus Cholecystitis Biliary colic Congestive hepatomegaly Hepatitis Perforated duodenal ulcer ```
84
Causes of RLQ pain
Appendicitis Caecal diverticulitis Merkel diverticulitis Mesenteric adenitis
85
Causes of lower abdominal pain - R or L
``` Abdominal or psoas abscess Abdominal wall haematoma Cystitis Endometriosis Strangulated hernia IBD PID Renal stone Ruptured AAA Ectopic pregnancy Ovarian cyst torsion ```
86
Define diarrhoea
Passage of >200g of stool per day | Can be acute or chronic
87
Categories of diarrhoea
OSMOTIC - when unabsorbable water solutes remain in the bowel and retain water - Stops with fasting - Examples: sorbitol, malabsorption causing high concentration in lumen, absorptive defect e.g. lactase deficiency SECRETORY - Bowel secretes more electrolytes and water - Persists with fasting - Causes: infection, malabsorption. drugs (colchicine, quinine), endocrine tumours - Enterotoxins cause block of Na/H+ exchange or absorption of Cl- INFLAMMATORY - reduced surface area or contact time - Causes: bowel resection, IBD, Coeliac, shigella
88
Causes of acute diarrhoea
Likely to be infective bacteria: salmonella, campylobacter, shigella, E.coli, C. Diff. bacillus cereus viral: norovirus, rotavirus, CMV, hep A parasite: giardia, Drugs: antibiotics, cytotoxic drugs, PPIs, NSAIDs Ask about recent travel abroad
89
Causes of chronic diarrhoea
``` IBS IBD Bowel resection Coeliac disease Pancreatic insufficiency Lactose intolerance Colon cancer Lymphoma Hyperthyroidism Diabetes ```
90
Red flags for diarrhoea
``` Blood Pus Fever Signs of dehydration Chronic Weight loss ```
91
Management of acute diarrhoea
1. Enquire about red flag symptoms 2. Assess for dehydration 3. Offer Oral rehydration therapy - 100ml per episode. if sever then IV 5% dextrose 4. Stool cultures 5. Faecal examinati0on for parasites and ova 6. Faecal alpha 1 antitrypsin levels - high in entroinvasive infections usually self-limiting Only requires supportive treatment
92
Causes of constipation
- lack of fibre or fluid intake - immobility - old age - bowel obstruction: volvulus, adhesions, hernia, faecal impaction, strictures - IBS - Drugs: opiates, anti-cholinergic, calcium antagonists, iron supplements, anatacids, antipsychotics, antispasmodics, general anaesthetics - Colon cancer - Obstruction: strictures, Crohn's, pelvic mass - Metabolic/endocrine: hypothyroid, hypercalcaemia, hypokalaemia - Neuromuscular: spinal or pelvic nerve injury, diabetic neuropathy - Parkinsonism - Diabetes - Pregnancy - Depression
93
Red flags for constipation
``` Distended abdomen Vomiting Blood in stool Weight loss Severe constipation with recent onset or worsening Over 50 ```
94
Investigations for constipation
Blood tests FBC, U&E, TFTs, calcium Blood glucose Abdominal X-ray for masses or obstruction PR exam barium enema or colonoscopy/sigmoidoscopy
95
Rome III criteria for functional constipation
Functional constipation. must include 2 or more of: - straining - lumpy/hard stools - sensation of incomplete evacuation - Sense of anorectal obstruction - Manual manoeuvres - Less than 3 per week Each symptom must be present >25%
96
Bristol Stool Chart
1. Separate hard lumps 2. Lumpy sausage shape 3. Like sausage with cracks 4. Sausage, smooth and soft 5. Soft blobs with clear cut edges 6. Fluffy with ragged edges (mushy) 7. Watery, no solid pieces
97
Management of constipation
INITIAL if no alarm - Patient education - High fibre diet - Increase fluids - Increase exercise - Bulk laxatives 1. Bulk laxatives e.g. ispaghula husk 2. Osmotic or stimulant laxatives 3. Refer
98
Symptoms of IBS
6 month history of either: abdominal pain or discomfort, bloating or change in bowel habit - Pain improves in defaecation - Altered passage of stool: straining, urgency, incomplete evacuation - Abdominal bloating - Distention - Symptoms aggravated by eating - Rectal mucus - lethargy - Nausea - Backache - Urinary frequency and urgency - Headaches and migraine
99
Epidemiology of IBS
10-20% of population Increased in women (2:1) Peak between 20-40 RF Emotional stress Food poisoning or gastroenteritis Mental health condition
100
Criteria for IBS
Rome III Criteria Recurrent abdominal pain for over 3 months, at least 3 days per month, PLUS 2 or more of: - Pain improves with defaecation - Change in stool frequency - change in stool form
101
Pathophysiology of IBS
Psychological factors, altered GI motility, altered visceral sensation 7-30% develop IBS following gastroenteritis
102
Investigations for IBS
``` FBC, ESR, CRP Coeliac screen CA-125 if ?ovarian cancer Faecal calprotectin if ?IBD Colonoscopy or sigmoidoscopy Refer if any RED FLAGS ```
103
Classification for IBS
IBS-C - constipation - loose stool <25%, Hard stools >25% IBS-M - mixed - both hard and soft stools >25% of the time IBS-D - diarrheoa - loose stool >25%, hard <25%
104
Treatment of IBS
Constipation - high fibre diet, bulk forming laxatives (ispaghula husk) or osmotic (but avoid lactulose) Diarrhoea - reduce fibre + loperamide, codeine, colestyramine Pain and bloating - use spasmolytic drugs e.g. amitryptiline Treat the symptoms of the patient CBT, hypnotherapy, psychotherapy
105
Symptoms of achalasia
``` Dysphagia Affecting solids more than liquids Regurgitation in 80% Chest pain in 50% - occurs after eating, retrosternal Heartburn is common Weight loss suggests malignancy Nocturnal cough No signs! ```
106
Pathophysiology of achalasia
Smooth muscle layer of oesophagus has impaired peristalsis and failure of the sphincter to relac causes functional stenosis or stricture Most have no underlying cause
107
Investigations for achalasia
CXR - vastly dilated oesophagus Barium swallow - usually precedes endoscopy when investigating dysphagia as can perforate malignancy with endoscope. Birds beak - narrow segment in distal oesophagus. Endoscopy Manometry - is GOLD STANDARD - can detect 90% of cases. High resting pressure in cardiac sphincter, incomplete relaxation on swallowing and absent peristalsis If no radiological evidence - it may be pseudoachalasia
108
Management of achalasia
Calcium channel blockers and nitrates - reduce pressure in lower sphincter. Only works in 10% Heller myotomy - divide muscles longitudinally (90% success) Pneumatic dilation - balloon inflated to rupture muscle, leaving mucosa intact Enodscopic injection of botulinum but recurs in the majority. Endoscopic stent insertion
109
Causes of dysphagia
``` benign stricture: schataki ring, GORD Malignant stricture: SCC, adenocarcinoma Stroke Achalaisa Parkinson's Motor neurone disease Myasthenia gravis ```
110
Epidemiology of oesophageal cancer
13th most common in the UK, 8th most common worldwide Increased in age - most are over 60 Increased in men High in East African and Asia Increasing prevalence of adenocarcinoma, decreasing SCC ``` RF Adenocarcinoma - Caucasian - Barrett's oesophagus - Obesity ``` SCC - Achalasia - Corrosive strictures - Coeliac - African Both - Smoking - Alcohol - Radiation to area - Genetics - Diet (high sat fat)
111
Symptoms of oesophageal cancer
``` Dysphagia (initially liquids then solids) Vomiting Anorexia Weight loss Blood loss/ melaena Odynophagia (painful swallowing) Hoarseness Retrosternal or epigastric pain Persistent cough Lymphadenopathy ```
112
Types of oesophageal cancer
Adenocarcinoma - more common in lower oesophagus. Mainly progression from Barrett's oesophagus Squamous cell carcinoma - can be anywhere along the oesophagus
113
Investigations for oesophageal cancer
FBC - anaemia U&Es, LFTs for baseline CRP - can be raised Glucose Urgent endoscopy and biopsy CXR for mets and spread Double contrast barium swallow Staging - FDG PET/CT or MRI Endoscopic Ultrasound
114
Prognosis of oesophageal cancer
50% have mets at diagnosis presents late as 75% of lumen needs to affected around the circumference before difficulties present 20-25% 5 year survival rate AC and SCC have the same prognosis
115
Management of oesophageal cancer
Primary = surgery +/- chemo +/- radiotherapy Surgery - antibiotic and antithrombotic prophylaxis given - If early, endoscopic muscosal resection - If late: oesophagectomy endoscopically if possible - Abdominal lymphadenectomy is beneficial - Chemo and radiotherapy shrink tumour prior to resection Palliative - Can use chemo/radiotherapy to decrease bulk - Fit stent to allow swallowing - PEG for feeding - ANALGESIA
116
Epidemiology of GORD
25% of adults, 5% have daily symptoms More common in men RFs - Obesity - Pregnancy - Systemic sclerosis - Drugs: nitrates, TCAs, anticholinergics, calcium channel blockers - Hiatus hernia - Increased intra abdominal pressure - Smoking - Alcohol - Large meals
117
Symptoms of GORD
``` Heartburn worsened on lying or bending down Retrosternal discomfort Regurgitation Pain on swallowing Nocturnal cough Excessive salivation Chronic hoarseness Acid brash Pain relieved by antacids ``` No signs
118
Endoscopic findings in GORD
60-70% have normal endoscopy (non-erosive reflux disease) 20-30% erosive oesophagitis 6-10% Barrett's oesophagus Can show basal hyperplasia, inflammation, Goblet cell metaplasia, thinning of squamous layer or dysplasia
119
Pathophysiology of GORD
Spectrum of disorders from endoscopy negative GORD to oesophageal damage 3 main causes: - Poor oesophageal motility - Dysfunction of lower oesophageal sphincter (permanent or intermittent relaxation or increase in abdominal pressure) - Delayed gastric emptying
120
Investigations for GORD
FBC to exclude anaemia H.pylori stool test (stool antigen test) Endoscopy +/- biopsy (must be drug free for 2 weeks) Barium swallow
121
Management of GORD
Assess for possibility of GI bleed Simple lifestyle advice: healthy eating, weight reduction, smoking cessation. Avoid precipitants: smoking, alcohol, coffee, chocolate, fatty foods, acidic foods e.g. tomatoes, oranges Raised head of bed Avoid eating late at night If H.pylori positive, treat Full dose PPI for 4 weeks. Can offer H2 receptor agonist therapy as alternative. Antacids as required If very severe and uncontrollable, can fit magnetic band around LOS to aid closure.
122
Urgent referral criteria for GORD
``` Dysphagia Dyspepsia + weight loss/anaemia Dyspepsia new onset in over 55s Dyspepsia plus one of: - FHx of upper GI cancer - Barrett's - Pernicious anaemia - upper abdominal mass - known dysplasia ```
123
Complications of GORD
``` Oesophagitis Ulceration Anaemia Stricture Barrett's oesophagus ```
124
What is Barrett's oesophagus
Premalignant condition Normal squamous lining is replaced by columnar cells Adaptive response to GORD
125
Classification of GORD
Savary-Miller Grading system 1. single or multiple erosions on single fold 2. multiple on multiple folds 3. multiple circumferential erosions 4. ulcers, stenosis or oesophageal shortening 5. Barrett's Can use Los Angeles Grades A-D
126
Epidemiology of peptic ulcer disease
Of the 1% with reflux receiving endoscopy, 13% will have peptic ulcer disease 1 per 1000 (0.1%) Decreasing in Western populations Increased in males RFs - Smoking - Alcohol - NSAID or steroid use
127
Symptoms of peptic ulcer disease
``` Post-prandial epigastric pain Relieved by food Nausea Oral flatulence Bloating Intolerance of fatty foods Heartburn Pain can radiate to the back if ulcer is posterior Fatigue or dyspnoea if anaemia melena ``` Signs Epigastric tenderness
128
Aetiology of peptic ulcers
``` H. pylori Bile acids NSAIDs Steroids pepsin Stress Smoking Changes in mucus consistency Alcohol ```
129
Pathophysiology of H.pylori
``` Gram negative spiral Lives deep beneath mucus layer Closely adheres to epithelial surface Uses an adhesin (BabA) Any acidity is buffered by urease ```
130
Pathphyiology of peptic ulcers
1. Depletion of somatostatin 2. increase gastrin release from G cells 3. Increased acid secretion 4. Increased acid load in duodenum will cause metaplasia
131
Investigations for peptic ulcer disease
FBC - iron deficiency anaemia H. pylori test - 13C breath test or stool antigen test Endoscopy if there are any warning signs
132
Treatment of peptic ulcers
Lifestyle advice: stop smoking and alcohol If H.pylori positive treat If taking NSAIDs = STOP If neither is positive (rare), endoscopy for ? Zollinger-Ellison syndrome Endoscopic ablation if actively bleeding
133
Complications of peptic ulcers
Perforation (more common in duodenal) Gastric outlet obstruction Bleeding Anaemia
134
Treatment of H.pylori
TRIPLE therapy for 7 days Clarithromycin PPI Amoxicillin or metronidazole
135
Functional dyspepsia
Chronic discomfort in the upper abdomen without any organic disease (as seen in GORD) Drug treatment not useful. Prokinetic drugs e.g. metoclopramide may be helpful
136
Define cholelithiasis and choledolithiasis
Formation of gall stones within the gall bladder | Choledocholithiasis - stones in the common bile duct
137
Epidemiology of gallstones
10-15% of Western population but only 10-25% of these become symptomatic Increases with age Increased in women increased in middle age Fair, fat, fertile, female and 40 ``` RF FHx Obesity Pregnancy Sudden weight loss Haemolysis (sickle cell) Loss of bile salts (ileal resection) Drugs (oestrogens, fibrates, somatostatin) Diabetes Oral contraception Crohn's ```
138
Symptoms of gallstones
70% are asymptomatic Pain in RUQ or epigastrium, can radiate to the back Pain begins post-prandially Pain is intense and dull Subsides spontaneously, after analgesia, vomiting, antacids, defaecation, flatus or positional changes Sporadic and unpredictable episodes Persists from 5 minutes to 24 hours Nausea or vomiting can accompany pain Intolerances to fats Abdominal distension Can have diaphoresis (excessive sweating)
139
Signs of gallstones
No findings if asymptomatic Tachycardia (due to pain) No peritoneal signs If complications: can have jaundice, positive Murphy's sign or pancreatitis
140
Types of gallstones
Cholesterol stones (80%) Large, solitary and radiolucent Increased with increased cholesterol Pigment stones (20%) Small, black and friable, irregular radiolucent RFs - haemolysis and cirrhosis Occurs with high levels of unconjugated bilirubin Calcium bilirubinate can crystalise to form stones Mixed stones - calcium salts, pigment and cholesterol, 10% are radio-opaque Brown pigment stones <5%, due to stasis and generally present with E.coli or Klebsiella infection
141
4 stages of gallstone formation
1. Lithogenic state in which conditions favour gall stones: high cholesterol, low bile sales 2. Asymptomatic gallstones 3. Symptomatic gallstones with episodes of biliary colic 4. Complicated cholethiasis
142
Investigations for gallstones
Blood tests: FBC, LFTs, amylase and lipase If uncomplicated or simple biliary colic, will be normal Abdominal x-ray to rule out obstruction US - best way to see stones. They are usually echogenic, mobile and cast an acoustic shadow. ERCP - can be used to see and remove stones in CBD MRCP - using MRI, reserved for suspected choledolithiasis.
143
Management for gallstones
Manage with pain with morphine Laparoscopic cholecystectomy If unfit for surgery can surgical drain the gallbladder (cholecystotomy) If stones in bile duct then - cholecystectomy and CBD exploration and stone extraction Consider mechanical or shock wave lithotripsy If asymptomatic watch and wait.
144
Reasons for cholecystectomy in asymptomatic patients
``` stone > 2cm high risk of GB carcinoma Non-functioning GB Sensory neuropathy of abdomen Sickle cell anaemia Cirrhosis or portal hypertension Children Transplant candidates Diabetics ```
145
Complications of gallstones
``` Cholangitis if in biliary tree GB empyema Gallstone ileus Fibrosis of gallbladder Loss of gallbladder function GB carcinoma ```
146
Epidemiology of cholecystitis
``` 10% have gallstones 1/3 get cholecystitis Increases with age increased in females Although acalculus is more common in men ``` ``` RFs Gallstones Trauma Obesity Rapid weight loss Pregnancy Crohn's Hyperlipidaemia ``` ``` RF for acalculus Major surgery Long term parenteral nutrition Sepsis Prolonged fasting ```
147
Symptoms of cholecystitis
Upper abdominal pain may radiate to right shoulder or scapula Pain begins in epigastrium and localises to RUQ Starts colicky but becomes constant in all cases nausea and vomiting Fever
148
Signs of cholecystitis
``` Raised WCC Positive Murphy's sign Local peritonism Fever Tenderness in epigastrium/RUQ Tachycardia Jaundice Guarding/rebound tenderness palpable GB ```
149
Pathophysiology of cholecystitis
90% are calculous Stone obstructs cystic duct causing distension of GB Blood flow and lymph drainage of the gallbladder are compromise and can cause ischaemia and necrosis Acalculous 10% Cause unclear. If fasting GB has no CKK stimulus and so bile remains stagnant
150
Causes of cholecystitis
GALLSTONES ``` Acalculus MI Sickle cell Salmonella Diabetes AIDS CMV pregnancy ```
151
Investigations for cholecystitis
Blood tests - Raised WCC Raised ALT and AST Check amylase and lipase for pancreatitis Urinalysis to rule out pyelonephritis and renal stones Pregnancy test CXR to rule out lower lobe pneumonia or see radiopaque stones US - thickened gall bladder wall >3mm, pericholecystic fluid or air on GB or GB wall CT with IV contrast
152
Treatment for cholecystitis
``` Rest IV hydration Bowel rest - no intake Correct electrolyte imbalance Analgesia IV antibiotics (tazocin/metronidazole) Laparoscopic cholecystectomy ERCP ```
153
Triad of ascending cholangitis
Charcot's triad RUQ pain Jaundice Fever Reynold's pentad adds confusion and hypotension
154
Cholangitis
Infection of biliary tract Majority of cases are due to gall stones 10-30% are due to benign strictures, post-op damage, tumours, bacteria (anaerobes) and parasites Carries significant risk of death due to shock or multi organ failure
155
Blood test results in cholangitis
``` Raised CRP or WCC Increased LFTs (ALP, AST, ALT, GGT) ```
156
Epidemiology of gastric cancer
8th most common cancer Increases in Asia and South America Increases with age More common in men 50% in pylorus, 25% in lesser curve, 10% cardia, 2-8% lymphomas ``` RFs H.pylori infection Smoking Diet: rich in pickles, salt, smoked meats and fish FHx Poor socioeconomic status Previous gastric surgery Obesity ```
157
Pathophysiology of gastric cancer
Correa's cascade - Chronic non-atrophic gastritis - Atrophic gastritis - Intestinal metaplasia - Dysplasia - Cancer Can spread to ovaries 2 main types: - Intestinal (type 1) with well formed glandular structures. Ulcerating lesions with heaped rolled edges. Strong environmental association - Diffuse (type 2) poorly cohesive cells. Poorer prognosis. Loss of expression of E=cadherin molecule
158
Investigations for gastric cancer
FBC for anaemia LFTs Rapid access flexible endoscopy: Gastroscopy and biopsy Endoscopic US for local staging and depth Chest/Abdo/Pelvis CT 18F PET/CT
159
Management of gastric cancer
Surgery is treatment of choice If distal then subtotal gastrectomy, if proximal then total If curable remove D2 lymph nodes Perioperative chemotherapy is standard with 5-FU, but can be palliative Blood transfusion if anaemia Corticosteroids for management of anorexia
160
Prognosis of gastric cancer
Overall survival rate 15% 11% live 10 years Younger patients have a better prognosis Poorer prognosis if paraneoplastic syndrome
161
Epidemiology of pancreatitis
150 per million 3% of all abdominal pain in hospital High in USA & Scandinavia Equal gender distribution RF - Alcohol abuse - Some family history (alpha 1 antitrypsin deficiency) - Hyperlipidaemia - Gallstones - CF - Smoking - Oestrogens - Hypothermia - Congenital abnormalities - Vasculitis
162
Symptoms of acute pancreatitis
``` Severe upper abdominal pain Decreases steadily over 72 hours Pain focused in LUQ or epigastrium Penetrates tot he back Sudden onset vomiting ```
163
Signs of acute pancreatitis
``` Mild pyrexia (common), rare but can have hypothermia Hyperlipidaemia Tachycardia Jaundice Abdominal tenderness and rigidity Bowel sounds in early phase Paralytic ileus causes absent bowel sounds Hypoxaemia ``` ``` In severe: Gross hypotension Pyrexia Tachypnoea Ascites Pleural effusion Body wall staining around umbilicus (Cullens sign) or Grey Turner's (flanks) ```
164
Cullen's sign
Body wall staining around the umbilicus
165
Grey Turner's sign
Body wall staining on the flanks
166
Aetiology of acute pancreatitis
90% are caused by gallstones, alcohol, post-ERCP or idiopathic ``` Idiopathic Gallstones Ethanol Trauma Steroids Mumps/malignancy Autoimmune Scorpion bite Hyperlipidaemia ERCP Drugs ``` Viral causes - Coxsackie B, hepatitis, mumps Drugs - thiazides, valproate, azathioprine IBD Alpha 1 antitrypsin deficiency Sclerosing cholangitis Vasculitis Hyperparathyroidism
167
Pathophysiology of acute pancreatitis
Occurs as a consequence of premature activation of zymognes releasing proteases that digests surrounding tissues. Severe is dependent on balance between proteases and anti-proteolytic factors (Alpha anti-trypsin_ Occurs because of one of: - Defective intracellular transport and secretion of pancreatic zymogens - Pancreatic duct obstruction - Hyperstimulation of pancreas (alcohol/fat) - Reflex of infected contents into CBD
168
Investigations for acute pancreatitis
FBCs, U&Es, LFTs, CRP, glucose - Amylase 3x normal - Lipase is more sensitive and specific - Hypocalcaemia is common Abdominal x-ray - rule out perforation and obstruction CXR - at show pleural effusions or ARDS CT + contrast is bloods unclear After 4 days can assess for complications - pancreatic swelling, fluid collection, change in density of gland US - poorly visualised in 25-50% of cases See swollen pancreas, dilated CBD, free peritoneal fluid MRI for acute abdominal wall oedema Laparoscopy if inconclusive results
169
Treatment of acute pancreatitis
MILD - Manage on general ward - Pain relief with pethidine +/- benzos - NBM - IV fluids - Nasogastric tube if severe vomiting - Antibiotics for specific infections - resume oral fluids once symptoms resolve and normal blood tests MODERATE - Treat in HDU or ITU - If pancreaitic necrosis - IV antibiotics and peritoneal fluid culture - Enteral nutrition via NG below Ligament of Treitz - Surgery only if infection and necrosis = open surgical debridement - Early ERCP for co-existing cholangitis
170
Complications of acute pancreatitis
Pancreatic necrosis (if infected then 3x mortality) - confirmed by CT. Infected necrosis - fatal without intervention (Infection in 30-70% of necrosis) - IV antibiotics and agrressive surgical debridemnt Fluid collections Pancreatic abscess - occurs several months after the attack, requires surgery Acute pseudo-cyst - occurs 4 weeks after the attack. Can rupture/haemorrhage, requires surgery Pancreatic ascites from collapsed pseudocyst Acute cholecystitis Systemic complications - pulmonary oedema, pleural effusions, consolidation, hypovolaemia, shock, renal dysfunction, hypocalcaemia, hypomagnesaemia, hyperglycaemia, GI haemorrhage, Weber-Christian disease
171
Prognosis of acute pancreatitis
80% have mild and recover without complications 5% mortality in mild 30% mortality in severe
172
Classification of acute pancreatitis
Glasgow Prognostic Score Ranson's criteria (very similar) 3+ = severe pancreatitis Can also use APACHE II = 8 or more is severe
173
Causes of raised amylase
``` Pancreatitis Renal failure Ectopic pregnancy Diabetic ketoacidosis Perforated duodenal ulcers Mesenteric ischaemia ```
174
Symptoms of chronic pancreatitis
``` Episodes of exacerbation with intervening remission or continuous pain Abdominal pain Epigastric and radiating to the back Nausea and vomiting Decreased appetite Weight loss Steatorrhoea ```
175
Signs of chronic pancreatitis
Exocrine dysfunction - Malabsorption - Diarrhoea/steatorrhoea - Protein deficiency Endocrine dysfunction - diabetes mellitus Abdominal tenderness
176
Risk factors for chronic pancreaitis
``` Alcohol abuse Smoking Genetics (PRSS1, CFTR, SPINK1) Male Black ```
177
Pathophysiology of chronic pancreatitis
Obstruction OR reduction of bicarbonate excretion These lead to the activation of pancreatic enzymes - causing pancreatic necrosis Alcohol causes proteins to precipitate in pancreatic ducts leading to pancreatic dilation and fibrosis. It leads to ductal plugging and obstruction - Alcohol most common cause - Increased protein secretion, decreases fluid, decreased bicarbonate production 2 pathological subtypes: - LARGE DUCT: dilation and dysfunction of large ducts visible on imaging. - Occurs more in men, steatorrhoea common, requires surgery to alleviate symptoms - SMALL DUCT: occurs more in women, no diffuse pancreatic calcification. Imaging normal - hard to diagnose. - Patients respond to pancreatic enzyme replacement
178
Hereditary pancreatitis
Rare Similar to chronic Genetic mutation in PRSS1 This increases autoactivation of chymotrypsin C Presents at a young age with epigastric pain Exocrine and endocrine dysfunction High incidence of pancreatic carcinoma
179
Tropical chronic pancreatitis
Developing countries Associated with type 1 diabetes Associated with CFTR and SPINK1 genes Similar to alcoholic pancreatitis presentation
180
Autoimmune chronic pancreatitis
``` High prevalence in Japan Elevated IgG and serum gammaglobulins Autoantibodies may be increased Steroid responsive. Reversible ```
181
Investigations for chronic pancreatitis
Blood tests - FBC - U&Es - LFTs - Calcium (hypocalcaemia) - Amylase (raised) - Glucose and HbA1c Secretin stimulation test - positive if pancreatic exocrine function damaged Serum trypsinogen, urinary D-xylose Faecal elastase All seen in malabsorption US - first line then CT -> ERCP - See pancreatic calcification MRCP Pancreatic biopsy - chronic inflammation, irregularly placed fibrosis, Rarely performed as high risk Tests of pancreatic function: - GOLD standard is collection of pure pancreatic juice after secretin injection (rarely used due to invasive nature) - Pancreolauryl test or PABA test - Faecal pancreatic elastase
182
Treatment of chronic pancreatitis
Supportive measures Lifestyle advice - smoking cessation, alcohol abstinence Pain relief - opiates ERCP may reduce pain Malabsorption is treated by pancreatic enzyme replacement - Lipase treatment of choice Octreotide (somatostain analogue) inhibits pancreatic enzyme secretion and CCK levels Surgery - pseudocyst decompression, ERCP + lithotripsy - If large duct dilation: pancreaticojejunostoy - Pancreatoduodenectomy
183
Complications of chronic pancreatitis
``` Cobalamin Deficiency (B12) Diabetes Pericardial, peritoneal and pleural effusions Pseudocysts Pancreatic carcinoma ``` Increased risk of morbidity and mortality. 1/3 die in 10 years
184
Epidemiology of hepatitis A
Very common in developing countries, particularly in early life Most common viral hepatitis High risk: India, Africa, South and Central America, Middle Esat ``` RFs - Personal contact - Occupation - residential home staff, sewage worker - Travel to high risk areas - ```
185
Hep A virus
``` Small unenveloped RNA virus Enterovirus in picornaviridae family Incubation period 2-6 weeks Spread through faecal oral route Can be vaccinated with ```
186
Symptoms of Hep A infection
More severe in older patients, children can be asymptomatic - Mild-flu like symptoms - Anorexia, nausea, fatigue, malaise, joint pain, mild headache - Following this: jaundice - Icteric phase: dark urine, pale stools, jaundice, abdominal pain, pruritus, arthralgia, skin rash
187
Pathophysiology of hepatitis A
1. Receptor binding 2. RNA uncoating 3. Tranlocation and proteolytic processing. Host ribosomes bind to form polysomes 4. RNA replication. Genome copied by viral RNA polymerase 5. Virion assembly 6. maturation and release. Shed via biliary tree into faeces Shedding greatest between 14-21 days after infection
188
Investigations for Hep A infection
Specific antibody tests - IgM antibody to Hep A (positive for 3-6 months) IgG occurs after and persists for many years LFTs - ALT>AST. Raised ALP Levels return to normal over several weeks Raised bilirubin Modest decrease in albumin Mild lymphocytosis common
189
Treatment for Hep A infection
Mainly supportive - fluids, antiemetics, rest Avoid alcohol until liver enzymes return to normal For immediate protection can give immune serum globulin
190
Prognosis of hep A infection
Excellent Self limiting No long term sequale No carrier state. No chronic liver disease Complications - cholestatichepatitis, autoimmune hepatitis, relapsing hep A infection 4-15 weeks after first illness.
191
Epidemiology of Hep B infection
High prevalence in sub-Saharan Africa, most of Asian and Pacific Islands 1 in 350 in UK Starting to decline due to vaccinations RFs - Homosexual males - Sex workers - IV drug users - HIV + patients - Sexual assault victims - Healthcare workers/needle stick injuries
192
Hep B virus
Double stranded DNA Hepadnoviridae family Incubation period 40-160 days (average 60-90) Can be e antigen positive or negative (positive = increase rate of replication) Transmission: vaginal or anal intercourse, blood to blood contact, vertical transmission
193
Hep B antibodys
HBsAg - hep B surface antigen Indicator of active infection If present after 6 months then chronic infection HBcAg - Hep B core antigen Detected by its antibody IgM then IgG HBeAg - Hep B e antigen Indicator of viral replication Chronic infection = HbsAg and anti-HBcAg (IgG)
194
Investigations for Hep B infection
Blood tests - HBsAg (only detected in first 3-5 weeks after infection - unless chronic infection) - HBsAg antibodies - in vaccinated people - HBeAg - if positive, active infection - HBcAg antibodies - past infection - Dane particles are Hep B virions, can have anti-Dane antibodies - Quantitative Hep B DNA - FBC, bilirubin, LFTs, clotting, ferritin, lipid profile, caeruloplasmin - Test for Hep C and HIV - Alpha fetoprotein and liver US for hepatocellular carcinoma screen
195
Management of Hep B infection
Avoid unprotected intercourse Notify HPA Supportive treatment - fluids, antiemetics, rest Avoid alcohol. Stop unnecessary medications ``` Give antiviral agents if - Fulminant hepatitis - HBeAg positive - Pregnancy with high HBV DNA Give: peginterferon alpha-21 or tenofovir ``` - Monitor ALT every 24 weeks, more often if cirrhosis - Test for HCC (US and alpha fetoprotein) Can give hepatitis B immunoglobulin to baby to reduce risk of vertical transmission or just after infection to decrease risk
196
Prognosis of Hep B infection
Cirrhosis 20% Faster progression in Hep C or HIV positive as well
197
Signs and symptoms of Hep B infection
``` Flu like illness - nausea, anorexia, mlaise, ache in RUQ Jaundice Disinclination to drink alcohol Dark urine Pale stool ``` Fever In decompensated - ascites, encephalopathy, Gi haemorrhage
198
Signs and symptoms of Hep C infection
Acute - asymptomatic, often diagnosed on routine blood testing 20-30% get jaundice Chronic - malaise, weakness, anorexia, abdominal pain Symptoms are worse with increased alcohol intake
199
Epidemiology of Hep C infection
Large number undiagnosed 214,000 in UK RF - Drug misuse - Blood transfusion pre-1991 - Sexual intercourse - Infected pregnant mother - Healthcare worker - Needlestick injury - Tattoo, body piercing - Sharing razors/toothbrushes
200
Hep C virus
Enveloped RNA virus Flavivirdae family Incubation period 6-9 weeks Hep C RNA can be found after 2-4 weeks, antibodies at 6-12 weeks Transmission - Parenteral, blood born, sexual contact, vertical transmission 6 genotypes - 1 = most common - 2, 3, 4, 5, 6
201
Investigations for Hep C infection
- Anti HCV serology - HCV RNA quantitative PCR - HCV antibody positive for life regardless of treatment - US: focal lesions, splenomegaly, cirrhosis - Liver biopsy to assess severity - Measures of severity: macroglobulin, haptoglobulin, apolipoprotein A1, GGT, total bilirubin, transient elastography - Test for Hep B and HIV
202
Treatment of Hep C infection
Advice - counselling, barrier contraception, alcohol abstinence, implications of being positive Drugs effectiveness is related to genotype Better response in type 2 and 3 - Weekly subcut peginterferon alpha2a
203
Prognosis of Hep C infection
50-85% become chronic carriers 15% will clear virus completely Cirrhosis in 20-30% of chronic 1-4% get HCC, 2-5% get liver failure Co-infection with Hep B or HIV = worse prognosis Type 1 more likely to clear spontaneously
204
Hep D virus
``` Single stranded RNA virus Enveloped spherical deltavirus Requires presence of Hep B to replicate Patients must be HBsAg positive Delta virus Blood bourne Clinically indistinguishable from Hep B infection ``` Replicated only in liver cells Increases risk of fulminant hepatic failure, chronic liver disease, cirrhosis and HCC with B+D Chronic in 30-50% Incubation 3-20 weeks
205
Hep E virus
Hepeviridae Non-enveloped single stranded RNA Spread via faecal oral route Self-limiting with no chronic infections Incubation 2-9 weeks Fulminant disease in 10% Mild flu like symptoms
206
Hep B blood test results - vaccinated
HBsAg antibody - positive HBsAg - negative HBcAg antibody - negative
207
Hep B blood test results - Acute infection
HBsAg - positive HBcAg antibody - positive HBcAg IgM - positive HBsAg antibody - negative
208
Hep B blood test results - chronic infection
HBsAg - positive HBcAg IgG - positive HBsAg antibody - negative
209
Hep B blood test results - natural infection (cleared)
HBsAg antibody - positive HBcAg antibody - positive HBsAg - negative
210
Define acute liver failure
Occurs when liver loses the ability to regenerate or repair so that decompensation occurs. Characterised by - - Hepatic encephalopathy - Abnormal bleeding - Ascites - Jaundice Fulminant hepatic failure - when failure takes place within 8 weeks of the onset of underlying illness Late onset/subacute fulminant - when it occurs during 8-26 weeks Chronic decompensated hepatic failure - after 6 months
211
Risk factors for acute liver failure
``` Chronic alcohol abuse Poor nutritional status Female Chronic Hep B/C infection Chronic pain and narcotic use Pregnancy Paracetamol Antidepressant therapy Medications Illicit drug use ``` FHx - Wilson's disease, haemochromatosis
212
Aetiology of acute liver failure
Toxins - alcohol, Paracetamol, Reye's syndrome, drugs (co-amoxiclav, ciprofloxacin, doxycycline, erythromycin), ectasy, cocaine Infections - viral hepatitis, EBV, CMV, viral haemorrhagic fevers Cancer - HCC or mets Pregnany related - acute fatty liver of pregnancy Autoimmune liver disease Metabolic - Wilson's disease, alpha 1 antitrypsin deficiency Vascular - ischaemia or veno-occulsive disease. Budd-Chiari syndrome
213
Presentation of acute liver failure
``` Nausea and vomiting Malaise Abdominal pain RUQ tenderness Drowsiness and possibly confusion Jaundice Abdominal distension - ascites, hepatomegaly Papilledema,, hypertension, bradycardia (from cerebral oedema) Asterixis Palmar erythema Hepatic encephalopathy ```
214
Investigations for acute liver failure
FBC - thrombocytopaenia, leucocytosis, anaemia LFTs - Very raised transaminases, raised ALP Raised INR, Raised bilirubin, raised ammonia, low glucose May have: raised lactate, raised creatinine Blood cultures - very susceptible to infection Viral serology Free copper (Wilson's), Paracetamol levels for OD ABG - metabolic acidosis Dopper US, CT or MRI Avoid contrast
215
Management of acute liver failure
Intensive care management Mannitol to decrease ICP Lactulose + neomycin to reduce ammonia AKI may require haemodialysis or haemofiltration FFP, platelets and anti-fibrinolytic drugs for abnormal bleeding Replace glucose as required
216
Complications and prognosis of acute liver failure
Infection - Spontaneous peritonitis common Cerebral oedema Haemorrhage Bleeding, sepsis, cerebral oedema, AKI, respiratory failure High morbidity and mortality Cause depends on outcome Higher survival if Paracetamol, hep A, pregnancy
217
Define Jaundice
Yellow discolouration caused by accumulation of bilirubin in tissue Not apparent until serum bilirubin is over 35 It can be pre-hepatic, hepatocellular, post-hepatic
218
Breakdown of haemoglobin
Haemoglobin broken down in spleen to biliverdin. Biliverdin in plasma converted to unconjugated bilirubin and bound with bilirubin Unconjugated becomes conjugated in liver by glucaronic acid Secreted into bowels where converted to urobilinogen by bacteria, secreted in stool as stercobilin
219
Presentation of jaundice
``` Any prodromal flu like illness may suggest viral hepatitis Pain suggest gallstones painless suggests cancer Change in colour of urine and stools Pruritus Weight loss Alcohol or drug use medication history! amitriptyline, erythromycin, COCP, rifampicin, salicylates ```
220
Examination of a patient with jaundice/signs of liver disease
``` Jaundice - skin and sclera Spider naevi Palmar erythema Gynaecomastia Testicular atrophy Flapping tremor Ascites Splenomegly Finger clubbing Peripheral oedema ```
221
Aetiology of pre-hepatic jaundice
Gilbert's syndrome - unconjugated hyperbilirubinaemia Haemolytic anaemia - spherocytosis, pernicious anaemia Thalassaemia Trauma Crigler-Najjar syndrome
222
Aetiology of hepatic jaundice
``` Viral hepatitis HCC Alcoholic hepatitis Autoimmune hepatitis Drug induce hepatitis (Paracetamol) Decompensated cirrhosis ```
223
Aetiology of post-hepatic jaundice
``` Gall stones Bile duct strictures Common duct stone Head of pancreas cancer Tumour at ampulla of Vater Pancreatitis GB cancer Primary biliary cirrhosis Primary sclerosing cholangitis ```
224
Blood test results in Pre-hepatic jaundice
Raised unconjugated bilirubin Normal AST, ALP, GGT Raised reticulocytes Normal INR, PT
225
Blood test results in hepatic jaundice
``` Raised bilirubin ** Raised AST ALT>AST Raised ALP Raised GGT Raised INR and PT Raised urobilinogen with raised or normal bilirubin ```
226
Blood test results in Post-hepatic jaundice
``` Very high bilirubin Raised AST ** Raised ALP ** Raised GGT Rasied INR and PT ALT>AST Raised urine bilirubin ```
227
Investigations for jaundice
``` FBC - reticulocytes and blood smear LFTs Hepatitis viral serology Serum ANA and anti-smooth muscle antibody for primary biliary cirrhosis Ferritin for ?haemochromatosis Alpha 1 antitrypsin levels Abdominal US MRI/MRCP Liver biopsy ```
228
What is anti-mitochondrial antibody seen in?
Primary biliary cirrhosis
229
What is anti-nuclear and anti-smooth muscle and microsomal antibody seen in?
Autoimmune hepatitis
230
What is alpha fetoprotein an indicator of?
Hepatocellular carcinoma
231
Tests for Haemochromatosis
Serum iron Transferrin Ferritin
232
Tests for Wilson's disease
Serum and urine copper | Serum caeruloplasmin
233
Antibody positive in Primary Sclerosing Cholangitis
Antinuclear cytoplasmic antibody
234
Epidemiology of alcoholic liver disease
Growing incidence More common in males Increases with age RFs Alcohol consumption - prolonged and heavy Hep C infection Female - more rapid progression, requires lower dose of alcohol to achieve Smoking Obesity Over 65 Hispanic Genetic predisposition - alcohol metabolising enzymes
235
Pathophysiology of alcoholic liver disease
3 stages: steatosis (fatty liver) --> alcoholic hepatitis --> alcoholic liver cirrhosis Alcohol converted to acetaldehyde by alcohol dehydrogenase. At thee same time NAD converted to NADH NADH inhibits gluconeogenesis and increases fatty acid oxidation Uses other pathways to metabolise alcohol and this generates free radicals
236
Symptoms of alcoholic liver disease
``` Abdominal pain Weight loss/gain Anorexia Fatigue Jaundice Nausea and vomiting If severe - peripheral oedema, abdominal distension ```
237
Signs of alcoholic liver disease
``` Hepatomegaly Palmar erythema Ascites Asterixis Telangiectasia Pruritus Fever Dupytren's contracture Gynaecomastia Hypogonadism Dementia Peripheral neuropathy ```
238
Investigations for alcoholic liver disease
FBC - anaemia, leucocytosis, thrombocytopaenia, raised MCV LFTs - Raised AST and ALT - AST>ALT - Raised or normal ALP - Raised GGT and bilirubin - Normal or prolonged PT and INR U&Es Hepatic US - Hepatomegaly, fatty liver, liver cirrhosis, liver mass, splenomegaly, ascites, portal hypertension Consider - hepatic virology, iron, ferritin, transferrin, copper, caeruolplasmin, AMA, ANA, AMSA, alpha 1 antitrypsin Biopsy
239
Management of alcoholic liver disease
Removal alcohol Thiamine for Wernicke-Korsakoff syndrome Diazepam for DTs Decrease weight, smoking cessation Nutritional supplements and multivitamins Immunisation - influenza, pneumococcal, hep A and B Corticosteroids - if hepatic encephalopathy Sodium restriction and diuretics Liver transplant
240
Prognosis of alcoholic liver disease
Improves with alcohol cessation With abstinence 5 year survival = 90%, without = 60% If advanced liver disease (jaundice, ascites, haematemesis = 35%
241
Epidemiology of fatty liver disease
``` 40-60 years NAFLD is equal in both sexes More prevalent in Hispanics NAFLD 20-30% of population Non-alcoholic steatohepatitis - 5% Fatty liver is found in 50% of heavy alcohol users and 94% of obese individuals ```
242
Define fatty liver disease
Steatosis - accumulation of fat in liver Steatohepatitis - fatty liver causing inflammation Can be divided into: - Alcoholic fatty liver disease - NAFLD - non alcoholic fatty liver disease Only difference is alcoholic consumption When inflammation is present can get NASH non-alcoholic steatohepatitis which can progress to cirrhosis and HCC
243
Causes of fatty liver disease
Metabolic syndrome - T2DM, impaired glucose tolerance, central obesity, dyslipidaemia, hypertension PCOS Alcohol exceess Starvation, rapid weight loss, gastric bypass surgery Total parenteral nutrition and re-feeding syndrome Hep B, C, HIV Medication - Amiodarone, tamoxifen, steroids, tetracycline, oestrogens, methotrexate Wilson's disease
244
Pathophysiology of fatty liver disease
Accumulation of triglycerides and other lipids in hepatocytes Result of defective fatty acid metabolism, mitochondrial damage (alcohol), insulin resistance or impaired receptors and enzymes Histologically undistinguished from alcoholic hepatitis Mallory's hyaline neutrophil inflammation and pericellular fibrosis
245
Symptoms of fatty liver disease
Most do not have symptoms picked up on routine blood tests May have fatigue, malaise or RUQ pain If advanced - ascites, oedema, jaundice
246
Investigations for fatty liver disease
Definitive diagnosis only from biopsy + histology - LFTs: mildly raised ALT relative to AST, reverses as disease progresses - If raised GGT then alcohol likely cause - Fasting lipids and glucose - FBC - Viral serology - US - hyperechoic bright imaging - Elastography can be used to determine degree of fibrosis - CT or MRI can show extent of disease - SteatoTest, NAFLD fibrosis score - BIOPSY
247
Management of fatty liver disease
Alcohol related fatty liver is managed with abstinence and diet - Weight loss - Control co-morbidities: BP, diabetes, cholesterol - Exercise - medications: statins, fibrates,, metformin - Bariatric surgery - Regular follow up
248
Prognosis of fatty liver disease
Steatosis - 1-2% develop cirrhosis in 202 years | Steatohepatitis - 10-12% have cirrhosis in 8 years
249
Define cirrhosis
Loss of normal hepatic architecture due to fibrosis with nodular regeneration. Implies irreversible liver disease and is the final stage of chronic disease from a variety of causes 80-90% of liver parenchyma needs to be destroyed before signs appear
250
Aetiology of cirrhosis
``` Alcohol Hep B Hep C Unknown cause NAFLD NASH Primary biliary cirrhosis Autoimmune Primary sclerosing cholangitis Wilson's disease Haemochromatosis Alpha 1 antitrypsin deficiency Chronic R heart failure Budd-Chiari syndrome Drugs - methotrexate ```
251
Pathophysiology of cirrhosis
Chronic injury to the liver results in inflammation, necrosis and eventually fibrosis Fibrosis is initiated by activation of stellate cells and upregulation of receptors for proliferative and fibrogenic cytokines Normal matrix replaced by collagens Loss of endothelial fenestrations --> impaired liver function Fibrosis causes distortion of hepatic vasculature and can lead to increased intrahepatic resistance and portal hypertension Portal hypertension can lead to oesophageal varices, hypoperfusion of kidneys, salt and water retention, Micronodular - caused by alcohol damage and biliary tract disease Macronodular - chronic hepatitis
252
Signs and symptoms of cirrhosis
Vague symptoms: anorexia, nausea and weight loss In a long period of compensate cirrhosis, patient is well. Decompensation leads to: - Hepatocellular failure - Ascites - Portal hypertension - HCC - Osteoporosis - Increased infections - particularly spontaneous bacterial peritonitis
253
Investigations for liver cirrhosis
Dependent on clinical suspicion of aetiology - Hypoalbuminaemia - FBC: anaemia, thrombocytopaenia, macrocytosis - U&E: hyponatraemia, poor renal function would indicate hepatorenal function - Raised ferritin in haemochromatosis Imaging - US of liver +/- CT/MRI to detect complications - CXR: elevated diaphragm and pleural effusion - BIOPSY: gold standard
254
Management of cirrhosis
Delay progression and prevent or treat any complications - Cholestyramine for pruritus - Preventative for osteoporosis - Prophylactic antibiotics in upper GI bleeding - Stop alcohol - Regular exercise
255
Complications of cirrhosis
``` Anaemia Thrombocytopaenia Coagulopathy Oesophageal varices Ascites Spontaneous bacterial peritonitis HCC Cirrhotic cardiomyopathy Hepatopulmonary syndrome Portopulmonary hypertension ```
256
Prognosis of cirrhosis
Calculated by Childs-Pugh-Turcotte Classification | Raised score has decreased prognosis
257
Define portal hypertension
Abnormally high pressure in the hepatic portal vein | Hepatic venous pressure gradient >10mmHg
258
Anatomy of hepatic portal vein
Veins that enter portal hepatic vein - Superior mesenteric vein (from small intestine) - Splenic vein - Inferior mesenteric vein (from large intestine)
259
Aetiology of portal hypertension
Pre-hepatic - Portal vein thrombosis - Splenic vein thrombosis - Extrinsic compression (tumours) Hepatic - Cirrhosis - Chronic hepatitis - Myeloproliferative diseases - Idiopathic - Toxins - Nodular Post-hepatic - Budd-Chiari syndrome - Constrictive pericarditis - R heart failure - Anti-leukaemic drugs/radiation from veno-occlusion of small veins
260
Pathophysiology of portal hypertension
Increased vascular resistance in portal venous system - liver damage activates stellate cells and myofibroblasts contributing to abnormal blood flow patterns Increased blood flow in portal veins - Splanchnic arteriolar vasodilation caused by excessive release of endogenous vasodilators Increased portal pressure opens up collaterals connecting to portal and systemic venous system
261
Collaterals to portal system
Gastro-oesophageal junction - producing varices Rectum Left renal vein Diaphragm Anterior abdominal wall via umbilical vein (caput medusae)
262
Budd-Chiari syndrome
Occlusion of hepatic vein leading to collateral opening up within the liver with blood diverting though caudate lobe whose short hepatic veins drain directly into IVC
263
Presentation of portal hypertension
``` Haematemesis or melaena Lethargy, irritability and changes in sleep (encephalopathy) Increased abdominal girth, weight gain Abdominal pain, fever (SBP) Pulmonary involvement Caput medusae Splenomegaly Ascites Jaundice Spider naevi Palmar erythema Confusion, asterixis Gynaecomastia Testicular atrophy Hyperdynamic circulation - bounding pulse, low BP, warm peripheries ```
264
Investigations for portal hypertension
LFTs, U&Es, glucose, FBC, clotting screen Abdominal US - liver and spleen size, ascites, portal blood flow and thrombosis Doppler for direction of flow in vessels Elastography for fibrosis Measure hepatic venous pressure gradient Liver biopsy
265
Management of portal hypertension
Difficult to treat = treat underlying cause - Beta blockers +/- nitrates or shunt procedure - Salt restriction and diuretics - Terlipressin and octreotide can assist control of variceal bleeding - TIPS: transjugular intraheptatic portosystemic shunt Connects portal and hepatic veins using stent. Decompresses portal system Prevents re-bleeding and ascites Has a role in: hepatorenal syndrome, hepatic hydrothorax, hepatopulmonary syndrome, Budd-Chiari syndrome
266
Complications of portal hypertension
``` Bleeding from gastric or oesophageal varices (90% get varices, 33% of these bleed) Ascites (SBP, hepatorenal syndrome) Portopulmonary hypertension Liver failure hepatic encephalopathy Cirrhotic cardiomyopathy ```
267
Presentation of hepatomegaly
Vague symptoms: weight loss, reduced appetite, lethargy May have jaundice, ascites etc. Smooth hepatomegaly: hepatitis, CHF, sarcoid, early cirrhosis Craggy hepatomegaly: HCC or 2y tumours
268
Aetiology of hepatomegaly
Apparent - low lying diaphragm, early cirrhosis Venous congestion failure - viral hepatitis, EBV, CMV, malaria, constrictive pericarditis, hepatic vein obstruction Autoimmune liver disease Biliary disease - extrahepatic obstruction, primary biliary cirrhosis, primary sclerosing cholangitis 2y cancers, HCC Amyloidosis, sarcoidosis Sickle cell, thalassaemia, haemolytic anaemia, myeloma, leukaemia, lymphoma Haemochromatosis, Wilson's disease, porphyuria, NAFLD Drugs - alcohol, drug induced hepatitis In children - TORCH (toxoplasmosis, other, rubella, CMV, herpes simplex)
269
Aetiology of ascites
``` Cirrhosis (transudate) Malignancy (exudate) Heart failure Nephrotic syndrome - hypoproteinaemia Protein losing enteropahty TB Pancreatitis Hypothyroidism Iatrogenic Budd-Chiari syndrome ```
270
Causes of haemorrhagic ascites
Malignancy Ruptured ectopic pregnancy Abdominal trauma Acute pancreatitis
271
Classification of ascites
Only if not affected and not associated with hepatorenal syndrome - Grade 1: MILD, only detected on US - Grade 2: MODERATE: moderate symmetrical distension of abdomen - Grade 3: LARGE - marked abdominal distension
272
Pathophysiology of ascites
Transudates are the result of increased pressure in hepatic portal vein e.g. due to cirrhosis Exudates are actively secreted due to inflammation - raised protein, LDH and WCC, low pH and glucose Sodium and water retention occurs due to peripheral arterial vasodilation and consequent reduction in effective blood volume - NO, ANP and prostaglandins vasodilation - Decrease blood volume leads to increase RAAS Portal hypertension - exerts a local hydrostatic pressure and leads to increase production of lymph and transudate into peritoneal cavity Low serum albumin - may contribute to low plasma oncotic pressure
273
Signs and symptoms of ascites
Abdominal distension and discomfort Weight gain - due to water retention Nausea Appetite suppression - due to compression of bowels and stomach Increased dyspnoea due to limited venous return from legs and impaired lung expansion Stigmata of liver disease and cirrhosis Virchow's node - if peritoneal carcinoma
274
Investigations for ascites
- Confirm presence of ascites - Find cause - Assess complications - FBC, U&Es, LFTs, TFTs, clotting US - can detect small amounts and show causative pathology CXR - pleural effusion, pulmonary mets, heart failure Aspiration of fluid - Neutrophils > 250 = SBP - Measure protein - transudate or exudate - Cytology for malignant cells
275
Management of ascites
Salt and water intake restriction Regular weights 1. Spironolactone (monitor for hyperkalaemia) 2. Loop diuretics (Monitor for hyponatraemia) 3. Paracentesis - if large or refractory ascites - TIPS if > 3 per month - Catumaxamab
276
Define hepatic encephalopathy
Spectrum of neuropsychiatric abnormalities in patients with liver disease after exclusion of other known brain disease. Can be covert or overt Grades 0-4 0 - subclinical, normal mental status (minimal changes in memory, co-ordination or concentration) 1 - mild confusion, euphoria or depression 2 - drowsiuness, lethargy, gross defects in performing mental tasks 3 - rousable, unable to perform mental tasks, disorientated in time and place. incomeprehensible speech 4 - coma +/- response to painful stimuli
277
Precipitating factors for hepatic encephalopathy
``` high dietary protein GI bleeding Constipation Infection, including SBP Diuretic therapy TIPS Surgery Progressive liver damage Development of HCC Sedative drugs ```
278
Features of hepatic encephalopathy
``` Personality changes Intellectual impairment Decreased level of consciousness Reversal of sleep rhythm Nausea and vomiting Confusion Irritability Weakness Coma Hyper-reflexia Increased tone Fetor hepaticus - sweet smell to breath Asterixis Constructional apraxia Decreased mental function ```
279
Investigations in hepatic encephalopathy
``` Diagnosed clinically Will have deranged LFTs - Psychometric tests - Increased ammonia levels - EEG (decreased alpha waves) - Visual evoked response ```
280
Management of hepatic encephalopathy
Early diagnosis Management of precipitating factors - Lactulose - decreased nitrogen load from gut - Antibiotics - lower amino acid production by decreasing concentration of ammonia forming colonic bacteria (neomycin, vancomycin, metronidazole) - IV fluids as required
281
Pathophysiology of hepatic encephalopathy
Ammonia is by product of colonic bacteria catabolism of nitrogenous sources such as ingested protein and secretion of urea nitrogen Impaired liver function leads to impaired ammonia clearance Cirrhosis leads to portosystemic shunting which also decreased ammonia clearance increased ammonia = alteration of cerebral concentration of aminio acids and this affects neurotransmitter synthesis
282
Phases of drug metabolism
Phase 1 - oxidation reactions catalysed by enzyme's of which P450 is the most important Phase 2 - conjugation Formation of covalent bond between drug and endogenous substrate - usually in hepatic cytoplasm, makes it water soluble for excretion
283
Rules for prescribing in liver disease
No general rules for modifying drug doses in liver disease Changes in metabolism alters efficacy and toxicity If hypoalbuminaemia then protein bound drugs may be present in toxic amounts Decreased clotting - increased sensitivity to anticoagulants Fluids overload can worse ascites Avoid hepato-toxic drugs
284
Renal control of BP
Decreased BP = decreased renal perfusion at juxtaglomerular apparatus = RENIN secretion from kidneys Angiotenisogen -- renin --> angiotensin I Angiotensin I --ACE (lungs --> angiotensin II
285
Functions of angiotension II
1. Increased sympathetics 2. Na+ and water retention 3. Aldosterone secretion 4. Arteriolar vasoconstriction 5. ADH secretion from posterior pituitary (increase water absorption) 6. Increased thirst
286
Epidemiology of renovascular disease
``` 7% of over 65s increases with age FHx of CV or renovascular disease More common in younger women (fibromuscular dysplasia) and older men (atherosclerosis) Increased in Caucasians ``` ``` RFs Obesity Hyperlipidaemia Hypertension Renal impairment Other vascular disease Diabetes Smoking ```
287
Aetiology of renal hypoperfusion
``` Renal artery atheroma Fibromuscular dysplasia Prolonged hypotension Embolic renal disease Renal artery or aortic dissection Neurofibromatosis Renal AV malformation Takayasu's arteritis ```
288
Pathophysiology of renovascular disease
Atherosclerosis is most common Normally develops at renal artery ostium on luminal surface of aorta/proximal renal artery Atheroma obstructs blood flow Chronic renal ischaemia In India and Far East - Takayasu's arteritits most common Fibromuscular dysplasia affects distal renal artery
289
Presentation of renovascular disease
Patients are often asymptomatic Hypertension - Abrupt severe onset in middle or older aged patients Biochemical or clinical evidence of renal impairment during treatment ARB or ACEi Decompensation of congestive heart failure - recurrent episodes of acute pulmonary oedema
290
Investigations for renovascular disease
``` U&Es Blood glucose 24 hour urine protein excretion Urinalysis for RBCs and casts Serology to rule out SLE or vasculitis Lipid profile - likely to have atherosclerotic disease Renal US ``` If thought to be amenable to intervention - angiography
291
management of renovascular disease
Optimise vascular profile - smoking cessation, diabetes, statins, hypertensive therapy Avoid ACEi and ARBs Avoid nephrotoxic drugs Angioplasty and stenting is first line (indicated in pulmonary oedema, severe for refractory hypertension) Open/endovascular surgery to reconstruct stenosed artery
292
Complications of renovascular disease
``` End organ damage from uncontrolled hypertension CKD AKI Decreased renal function Refractory angina ```
293
Normal GFR`
80-100 ml/min
294
Severity of CKD
``` Stage 1 - normal GFR with renal disease Stage 2 - GFR 60-90 Stage 3a - GFR 45-60 Stage 3b - GFR 30-45 Stage 4 - GFR 15-30 Stage 5 - <15 or renal replacement therapy ```
295
Causes of pre-renal kidney injury
True hypovolaemia (diarrhoea, bleeding, burns, haemorrhage) Relative hypovolaemia (HF, septic shock, hepatorenal failure) Renovascular disease Shock
296
Causes of intra-renal kidney injury
``` Glomeruli - glomerulonephritis Tubules - ischaemic tubular necrosis, nephrotoxic acute tubular necrosis, intra-tubular obstruction Pylelonephritis Acute interstitial nephritis Malignant HTN Scleroderma Vasculitis ```
297
Causes of post-renal kidney injury
Need bilateral obstruction for kidney failure - Bilateral pelvicourtetic junction (rare) - Bilateral ureteric - tumour, retroperitoneal fibrosis, stones - BOO - BPH, stones, tumour, neurogenic bladder - Urethra tumour, valves, stricture, foreign body
298
Drugs that vasoconstrict/dilate the afferent and efferent arterioles
Prostaglandins dilate afferent NSAIDs constrict afferent ACEi dilate efferent Angiotensin II constricts efferent
299
Proteinuria
Presence of protein in urine Suggestive of glomerular disease Measured by protein:creatinine ratio
300
Microalbuminuria
Measured by albumin:creatinine ratio | indicator of early diabetic nephropathy and capillary injury secondary to hypertension or vascular disease
301
Functions of the kidneys
- Maintain acid base balance - Potassium excretion - Excretion of waste produces - Sodium and water balance - Hormone production: - anaemia - bone disease
302
Symptoms of uraemia
``` Anorexia Change in taste Nausea and vomiting Pruritus Neuropathy Pericarditis Confusion Encephalopathy Coma ```
303
Pathophysiology of bone disease in renal disease
Kidney failure causes decreased production of 1,25-dihydroxyD3 - This decreases calcium absorption - Decreased calcium and increased phosphate causes raised PTH - Secondary hyperparathyroidism - This causes renal osteodystrophy and vascular calcification
304
Define AKI
Rapid deterioration of renal function resulting in an inability to maintain fluid, electroryes and acid base balance Decreased urine output Decreased GFR
305
RFs for AKI
``` Over 65 Heart failure Liver disease CKD PMH of AKI Diabetes Hypovolaemia Oliguria Haematological malignancy Urological obstruction Sepsis Iodinated contrast Nephrotoxic drugs Emergency surgery Reliance of carer for fluids ```
306
Pre-renal causes of AKI
Volume depletion - haemorrhage, severe D and V, burns Oedematous state - Heart failure, cirrhosis, nephrotic syndrome Hypotension - cardiogenic shock, sepsis, anaphylaxis CV - severe cardiac failure, arrhythmias Renal hypoperfusion - NSAIDs, COX2 inhibitors, ACEi, ARBs, AAA, renal artery stenosis, hepatorenal syndrome
307
Renal causes of AKI
Glomerulonephritis Thrombosis Haemolytic uraemic syndrome Acute tubular necrosis - prolonged ischaemia, nephrotoxins Acute interstitial nephritis - drugs, autoimmune, infection Vascular - vasculitis, polyarteritis nodosa thrombotic microangiography, cholesterol emboli Eclampsia
308
Post-renal causes of AKI
``` Calculus Blood clot Papillary necrosis Urethral stricture BPH Prostate cancer Bladder tumour Radiation fibrosis pelvic malignancy Retroperitoneal fibrosis ```
309
Symptoms of AKI
Decreased urine output nausea and vomiting Dehydration Confusion
310
Signs of AKI
Hypotension/ hypertension Large painless bladder if BOO Can be dehydrated with postural hypotension OR fluid overloaded - raised JVP, pulmonary oedema, peripheral oedema Pallor, rash, bruising
311
Detecting AKI
Raised creatinine >26 in 48 hours Over 50% increase in creatinine in 7 days Decreased urine output <0.5ml/kg/day for 6 hours
312
Investigations for AKI
Determine cause - Urinalysis and dipstick (if blood or protein consider acute nephritis) - Bloods - FBC - eosinophilia in acute interstitial nephritis, cholesterol embolic and vasculitis - U&E with creatinine (raised creatinine, raised potassium, metabolic acidosis) (If urea:creatinine over 2x then pre-renal - Coagulation studiues - CK, myoglobin for rhabdomyolysis - CRP - WCC for infection - ANA in SLE - ANCA in vasculitis - anti-GBM in Goodpasture's - US if obstruction suspected - CXR for pulmonary oedema
313
Sodium changes in pre-renal or renal AKI
Pre-renal has decrease urine sodium | Renal has increased urine sodium
314
Management of AKI
Largely supportive Treat cause Stop nephrotoxic drugs Monitor U&Es, creatinine, sodium, potassium calcium, phosphate, glucose - Identify and treat any complications (hyperkalaemia, acidosis, pulmonary oedema, bleeding - Loop diuretic for treating fluid overload - RRT if not responding to medical management with complications
315
Staging AKI
RIFLE stage 1 - creatinine 1.5-2x normal Stage 2 - 2-3x normal Stage 3 - >3x or RRT
316
Complications of AKI
Volume overload Metabolic acidosis Hyperkalaemia Spontaneous haemorrhage
317
Avoiding AKI when giving contrast
Give IV volume expansion - sodium bicarbonate and 0.9% NaCl | PLUS vitamin B1 and B2 to mop up free radicals
318
Define CKD
Abnroaml kidney function and/or structure Presence of kidney damage (albuminuria) OR Decreased kidney function (GFR<60 for 3 months)
319
Epidemiology of CKD
``` Very common Frequently undiagnosed Increases with age Mildly increased in females Increased in Blacks and Asians Approximately 10% of adult population ``` RFs - CV disease - AKI - Hypertension - Diabetes - Smoking - Untreated BOO - Chronic NSAID use
320
Aetiology of CKD
``` Diabetes (most common) Hypertension (2nd most common) Arteriopathic renal diseases Glomerulonephritis Infective or obstructive nephropathies hereditary renal disease e.g. PCKD Multi system disease with renal involvement e.g. SLE Neoplasms Myeloma Hypercalcaemia ```
321
Pathophysiology of CKD
Regardless of method of renal injury the cascade of events is the same 1. Renal injury = increased intraglomerular injury and glomerular hypertrophy (kidney attempts to adapt to nephron loss to maintain GFR) 2. Increased permeability to macromolecules. Toxicity to the mesangial cells. Mesangial cell expansion, inflammation, fibrosis and scarring 3. Injury causes increased angiotensin I, raised TGF-beta and increased collagen and scarring 4. Progressive renal scarring and loss of function - All CKD is associated with tubulo-interstitial disease thought to be secondary to decreased blood supply
322
Symptoms of CKD
``` Only in severe anorexia nausea and vomiting fatigue weakness pruritus dyspnoea peripheral oedema insomnia muscle cramp pulmonary oedema headache nocturia/polyuria (usually first due to loss of concentrating ability) then oliguria/anuria ```
323
Signs of CKD
``` Skin pigmentation Excoriations Pallor Postural hypotension HTN Peripheral oedema Peripheral vascular disease Pleural effusion Peripheral neuropathy Restless leg syndrome ```
324
When should CKD be screened?
AKI CV disease Structural renal disease e.g. renal stones or BPH Multisystem disease with renal involvement e.g. SLE FHX of end stage renal disease Hereditary renal disease Haematuria
325
Investigations for CKD
Gold standard is isotropic GFR, mainly eGFR Bloods - Urea and creatininie - Electoryles (raised potassium, decreased bicarb_ - Albumin (low - Calcium (can be normal, low or high) - ALP raised if bone disease - PTH raised - Cholesterol - FBC (normocytic normochromic anaemia) - ANA, ANCA and anti-GBM antibodies (Good pasture's) Urine - Dipstick = proteinuria - RBC or casts = proliferative glomerulonephritis - Pyuria = UTI, pyelonephritis - protein electrophoresis = myeloma ECG and echo for cardiac function Renal US - Small echogenic kidneys in CKD - Hydronephrosis in BOO CT for masses and cysts (be aware of implications of contrast) Renal biopsy
326
Management of CKD
``` Monitor regularly Lifestyle: control HTN and diabetes Review meds Avoid nephrotoxins Immunisation of pneumococcus and influenza ```
327
Complications of CKD
``` Anaemia Bone disease (renal osteodystrophy) Acidosis Hyperkalaemia Fluid overload Uraemia ```
328
Cause and management of anaemia in CKD
Erythropoetin deficiency Other causes: bone marrow fibrosis (2y to raised PTH), haemotinic deficiency, increased RBC destruction, increased blood loss (GI bleed, haemodialysis), ACEi Give recombinant human EPO Target Hb = 110-120 Iron replacement if required increases exercise tolerance Can casue HTN avoids HLA antigens from blood products
329
Causes of bone disease in CKD
``` Decreased 1,25-D3 Decreased bone mineralisation Decreased calcium absorption from fut Decreased calcium Raised ALP and phosphate Leads to osteomalacia ``` Low calcium also causes raised PTH Secondary hyperparathyroidism = increase osteoclastic activity OR iatrogenic bone disease. Transplant patients receive steroids post-transplant causing osteoporosis
330
Management of bone disease in CKD
Bisphosphonates to prevent osteoporosis Vitmain D supplements if required Calcium and phosphate control and suppression of PTH - Dietary restriction of phosphate - Oral calcium carbonate - Phosphate binders
331
Renoprotection in CKD
``` Keep BP <120/80 ACEi Add ARB] Add diuretic to prevent hyperkalaemia Add CCB (verapamil or diltiazem) ``` Statins for cholesterol Stop smoking Treat diabetes Normal protein diet
332
Possible endocrine abnormalities in CKD
``` Hyperprolactinaemia Decreased testosterone (increased ED) Increased LH Amenorrhoea Abnormal thyroid levels ```
333
Aetiology of obstructive nephropathy
Equal in gender Within lumen - Blood clot - Calculi - Tumourof renal pelvis or ureter Within Wall - Ureteric, urethral stricture - Congential urethral valves - Bladder neck obstruction - neurogenic bladder - Pinhole meatus - Functional failure from denervation - MS, spinal trauma Pressure from outside - Tumours - BPH - Retroperitoneal fibrosis - Pancreatitis - Chronic granulomatous disease - Retrocaval ureter - Crohn's
334
Pathophysiology of obstructive nephropathy
Urine flow depends on - pressure gradient from glomerulus to Bowman's capsule - Peristalsis of renal pelvis and ureters - Effects of gravity Obstruction causes increased intraluminal pressure Decreased pressure gradient Decreased GFR Increased hydrostatic pressure on nephrons Body tries to maintain dropping GFT by decreasing renal blood flow, causing ischaemia, causing nephron loss
335
Most likely locations for compression of ureters
Pelvi-ureteric junction (PUJ) Where urters cross pelvic brim (level of iliac vessels) Vesico-ureteric junction
336
Presentation of obstructive nephropathy
Upper urinary tract - Pain (especially if acute) Flank pain, dull, sharp or colicky. Often radiated to iliac fossa, testes or labrum - Ipsilateral back pain - Loin tenderness - Nausea and vomiting - Anuria - Polyuria if chronic or partial obstruction due to impairment of tubule concentrating capacity - Increased pain with alcohol, diuretics or high fluid intake Lower urinary tract - pain (suprapubic) - abdominal distension - IF chronic - urinary hesitancy, weak and narrow stream, dribbling, incomplete emptying
337
Investigations for obstructive nephropathy
U&Es and GFR - Raised urea, raised potassium - Metabolic acidosis - FBC: anaemia of chronic disease or evidence of infection - PSA if ?prostate Ca Urinalysis, microscopy and culture Cystoscopy if haematuria US - first choice imaging If abnormality then CT (CT gold standard for stones) Post void US to assess residual volume
338
Management of obstructive nephropathy
Symptom relief and relieving the obstruction - Analgesia and hydration - Relieve blockage
339
Define BPH
Benign prostatic hyperplasia Increase in the size of the prostate without malignancy Failure of apoptosis Begins in the transitional zone which is periurethral
340
Epidemiology of BPH
Increased with age 90% at 90 years Increased severity in Blacks Weak RFs - FHx - Smoking - Male pattern baldness - metabolic syndrome
341
Aetiology and pathophysiology of BPH
Prostate enlargement depends on potent androgen - DIHYDROTESTOSTERONE Thought to be due to age related hormonal factors with androgen imbalances Hyperplasia of epithelial cells in transitional zone and increased muscle tone Increased stromal:epithelial ratio
342
Scoring system for BPH
``` IPSS International Prostate Symptoms Score Mild 0-7 Moderate 8-19 Severe 20-35 ``` For each symptom 0 = not at all, 1 = less than 20% of the time, 2 =
343
Symptoms of BPH
``` Urinary frequency Urgency Hesitancy Terminal dribbling Poor stream Incomplete emptying Intermittent stream Staining nocturia ```
344
Examination finding in BPH
Palpable bladder of chronic obstruction or neurogenic bladder DRE: anal sphincter tone, prostate size - enlarged, texture and contour, firm, not hard and smooth Clear median sulcus
345
Investigations in BPH
``` DRE Urine dip and MSU FBCs, U&Es, LFTs PSA - cut off depends on age US may assist choice of treatment Post-void residual volume US Urine flow rate as baseline - Qmax Cystoscopy if ?urethral stricture or bladder cancer ```
346
Managmenet of BPH
- Wathc and wait if minimla symptoms and cancer excluded - Advise weight loss, healthy diet and exercise MEDICAL - alpha adrenergic antagonists to decrease tone in bladder neck TAMSULOSIN (alpha 1) or DOXASOZIN (if HTN and BPH) - 5 alpha reductase inhibitors - block conversion of testosterone of dihydrotestosterone FINASTERIDE - less side effects - Combination therapy if one fails - trial treatment for at least 1 year SURGICAL - TURP - shave prostate with diathermy - Complications: increased erectile dysfunction, retrograde ejaculation, can cause urethral stricture - Open prostectomy if over 8-0g
347
Complications of BPH
``` Urinary retention Recurrent UTIs Bladder calculi Impaired renal function (CKD) Haematuria ```
348
Cell types in glomerulus
3 cell types: - Endothelial cells - Epithelial cells - Mesangial cells
349
Types of glomerulonephritis
Diffuse - all glomeruli are affected Focal - some glomeruli are affected Global - all parts of the glomeruli are affected Segmental - some parts of the glomeruli are affected
350
Consequences of loss of glomerular basement membrane
Protein Loss | Haematuria
351
Histological patterns of glomerulonephritis
``` Minimal change GN Membranous GN Mesangial proliferative GN Focal segemental GN Focal segmental glomerulosclerosis Crescenteric GN Diffuse proliferative GN Mesagniocapillary GN ```
352
Nephrotic syndrome
Peripheral pitting oedema - decreased capillary oncotic pressure from hypoalbuminaemia Proteinuria Hypoalbuminaemia Hypercholesterolaemia - liver overworking to create albumin and increases production of cholesterol Most also have secondary hyperaldosteronism due to perceived hypovolaemic state as fluids in periphery - activates RAAS and increased aldosterone
353
Causes of nephrotic syndrome in children
1. Minimal change GN | 2. Focal segmental glomerulosclerosis
354
Causes of nephrotic syndrome in adults
1. Membranous GN 2. IgA nephropathy Diabetic nephropathy SLE Amyloidosis
355
Minimal change glomerulonephritis
Light microscopy is normal. Podocyte effacement Most common cause of nephrotic change in children Treat WITHOUT biopsy = can only be diagnosed with biopsy Most will respond to steroids Some children will relapse when steroids stopped
356
Focal segmental glomerulosclerosis
Not all glomeruli are involved and only parts are affected
357
Membranous glomerulonephritis
Most common cause of nephrotic syndrorme in adults Capillary loop thickened on light microscopy Silver staining will show spikes Presents with proteinuria and can cause progressive renal impairment 1/3 spontaneous recovery, 1/3 persistent proteinuria, 1/3 end stage renal failure Vast majority are autoimmune Treated with immunosuppression Common associations: adenocarcinoma (GI and bronchial), hep B, SLE, drugs (gold and penicillamine)
358
Common associations with membranous glomerulonephritis
GI and bronchial adenocarcinoma Hepatitis B SLE Drugs - gold and penicillamine
359
IgA nephropathy
Common glomerulonephritis Presents with haematuria Presence of IgA in mesagium Presents with visible haematuria 1-2 days post URTI 1/3 will progress to end stage renal failure over 20 years Prognosis worse if associated proteinuria, hypertension or abnormal scarring
360
Berger's disease
Also known as IgA nephropathy Common glomerulonephritis Presents with haematuria Presence of IgA in mesagium Presents with visible haematuria 1-2 days post URTI 1/3 will progress to end stage renal failure over 20 years Prognosis worse if associated proteinuria, hypertension or abnormal scarring
361
Alport's syndrome
``` Presents with non-visible haematuria Most commonly X-linked recessive More common in males Haematuria Proteinuria Progressive renal failure Sensorineural deafness Anterior lenticonus (eye lense issue) ``` Female carriers present with microscopic haematuria, normal renal function. They have a good prognosis
362
Nephritic syndrome
``` Haematuria Hypertension AKI Often oliguria Often some proteinuria Oedema may be present but due to oliguria Red cell casts in urine ```
363
Common causes of nephritic syndrome in children
Post-streptococcal glomerulonephritis Haemolytic uraemic syndrome Henoch-Schonlein purpura
364
Common causes of nephritic syndrome in adults
Goodpasture's syndrome ANCA associated vasculitis SLE Primary or secondary mesangiocapillary glomerulonephritis
365
Post-streptococcal glomerulonephritis
10-14 days post streptococcal sore throat Nephritic - haematuria, hypertension, AKI Antisreptolysin I titre positive No treatment Spontaneous recovery - supportive therapy Diffuse proliferative GN
366
Henoch-Schonlein purpura
Characteristic red rash on buttocks and extensor surfaces of the legs Skin or renal biopsy Would stain for IgA
367
Rapidly progressive glomerulonephritis
Causes of nephritic syndrome in adults Presents with AKI developing over days-weeks Histology would show crescenteric glomerulonephritis and vascular necrosis Serology would show ANCA - cANCA in Wegeners - pANCA in microscopy polyangiitis Early diagnosis and treatment gets better outcome Treat with immunosupprerssion - steroids and cyclophosphamide
368
Goodpasture's disease
Antibodies to glomerular basement membrane Presents with AKI and pulmonary haemorrhage Crescenteric glomerulonephritis with linear IgG deposition Anti-GBM antibodies VASCULITIS - ANCA positive Goodpasture's syndrome = any disease causing AKI and pulmonary haemorrhage
369
Mesangiocapillary glomerulonephritis/membranoproliferative
There are 3 different types and can present at any age Can be due to: - infection (Hep C or endocarditis) - Monoclonal gammopathy (myeloma or lymphoma) - Collagen vascular disease - Genetic and acquired complement disorders
370
Kimmelsteil-Wilson lesions
Seen in diabetic nephropathy
371
Amyloidosis and renal disease
Similar lesions to diabetic nephropathy But stain positive with Congo red Often present with nephrotic syndrome and progressive deterioration
372
AA amyloid
Chronic inflammation- RA, AS, psoriasis, Crohn's Hereditary familial Mediterranean fever Chronic pyogenic infection Multi-organ involvement
373
AL amyloid
Serum amyloid A component Causes: lymphoma, myeloma, MGUS, Waldeenstroms Paraprotein in blood or urine
374
Causes of secondary glomerulonephritis
``` Diabetic nephropathy Amyloidosis AA amyloid AL amyloid - lymphoma, myeloma, MGUS Cryoglobulinaemia Subacute bacterial endocarditis SLE Shunt nephritis ```
375
Define urolithiasis
Renal stones | Renal calculi are formed when urine is supersaturated with salt and minerals
376
Randall's plaques
Lead to the production of stone formation Calcium oxalate precipitates in GBM It accumuilates in subendothelial space of papillae leading to Randall's plaques causing calculus
377
Epidemiology of renal stones
``` 1/10 Most are asymptomatic 1/1000 - renal colic Increased in males Peak age 30-50 years Recurrence is common ``` Risk factors - Anatomical abnormality - FHx of renal stones - HTN - Gout - Immobilisation - Hyperparathyroidism - Dehydration - Hot climates - Cystinuria - Diuretics, calcium supplements - Metabolic disorders: chronic metabolic acidosis, hypercalcinuria
378
Aetiology of renal stones
Hypercalcaemia - hyperparathyroid, sarcoidosis Hypercalciuria - hypercalcaemia, increased dietary calcium, excessive resorption of calcium in immobilisation Hyperoxaluria - ingestion of high oxalate foods (spinach, rhubarb, tea), dietary calcium restriction, GI disease Hyperuricaemia - myeloproliferative disorders, gout, dehydration UTI - mixed stones (staghorn calculi) - mostly proteus Cystinuria - polycystic kidney disease, renal tubular acidosis Drugs = loop diuretics, steroids, antacids, theophylline
379
Renal stone make up
``` 65% calcium oxalate 15% calcium phosphate alone 10-15% magnesium ammonium sulphate 3-5% uric acid stones 1-2% cystinuria ```
380
Presentation of renal stones
Many are asymptomatic and are picked up during investigations for something else. - Renal colic: sudden severe pain in loin, moving to groin - Can have tenderness in loin or renal angle - Moving stone is more painful than static stone - Pain can radiate to testes, scrotum, labia or anterior thigh - More constant than biliary colic, short periods of relief or background dull ache - Dysuria - Fever - Rigors - Haematuria - Urinary retention - nausea and vomiting - Writing in agony - Decreased bowel sounds - Can be hypotensive
381
Investigations for renal stones
- Dipstick: red cells, leukocytes and nitrates (infection) ph >7 = proteus - MSU for culture, microscopy and sensitivities - Bloods: FBC, CRP, U&Es, calcium, phosphate, urate - Non-enhanced CT is imaging of choice - US is good for determining if any obstruction - Plain AXR for determining passage of stones - Stones analysis: all first time stone formers, patients with recurrent stones on preventative pharmacology, early recurrence after stone clearance, late recurrence after long stone free period (stone composition may change)
382
Management of renal stones
Hospital admission if: fever, solitary kidney, inadequate pain relief, inability yo take fluids, anuria, pregnancy ACUTE - NSAIDs: diclofenac, more effective than opioids - Provide antiemetics and rehydration therapy - Most stones will pass in 1-3 weeks - Conservative management for 3 weeks unlesds unable to manage pain, infection or obstruction - Medical expulsive therapy - nifedipine, tamsulosin - Surgical management: insert JJ stent. - To remove stones: extracorporeal shock wave lithotripsy, percutaneous nephrolithotomy - Open surgery in rare severe cases
383
Complications of renal stones
20% if symptoms in over 4 weeks - Complete blockage, decreased GFR - irreversible renal damage if over 48 hours - Infection/ pyelonephritis - Ureteric stricture
384
Prevention of renal stones
- Increased fluid intake - Decreased salt, oxalate and urate intake - Cranberry juice - Normal calcium intake - if stones are URIC acid stones: allopurinol - if stones OXALATE stones: calcium citrate - If stones CALCIUM stones: thiazide diuretics
385
Define UTI
Lower UTI = cystitis Upper UTI = pyelonephritis Uncomplicated = infection by usual pathogen in normal urinary tract Complicated = anatomical, functional or pharmacological factors predisposing to persistent or recurrent infection
386
Epidemiology of UTI
1-3% of GP consultations 1/3 of women have one before 24 50% will have one in their lifetime 2nd most common clinical indication for antibiotics Risk factors - Incomplete bladder emptying: prostatic obstruction, urethral stricture, uterine prolapse, MS, spina bifida, diabetic neuropathy - Recent instrumentation of renal tract - Antibiotic use - Abnormality in renal tract - Sexual activity - new sexual partner - Use of spermicide - Diabetes - presence of catheter - Pregnancy - Immunocompromised - Vaginitis
387
Aetiology of UTI
- Most care caused by E.coli - Other common organisms: protues mirabilis, enterococci, staph saprophyticus - Less common: Klebsiella, proteus vulgaris, candida albicans, pseudomonas - Less common organisms are more common in underlying pathology, immunosuppressed, catheterised or frequent infections
388
Presentation of UTI
Can be asymptomatic and only diagnosed on dipstick - Urinary frequency - Dysuria - Haematuria - Foul smelling urine - Cloudy urine - Urgency - Suprapubic/loin pain - Rigors - Urinary incontinence - Nausea and vomiting - Pyrexia - Confusion
389
Investigations for UTI
- Dipstick: positive nitrites and leukocytes - Urine culture: should be done in all men and in pregnancy or failed to respond to initial treatment - FBCs, U&Es, urea, creatinine (if complicated) - Blood cultures (if complicated) - US of upper tract to exclude obstruction or urolithiasis in pyelonephritis - Men = PR exam, women = pelvic exam - Refer for cystoscopy if: haematuria, men with >2 UTIs, renal tract disease, not responding to treatment
390
Management of UTI
Avoid risk factors, cranberry juice, increase fluids, avoid delaying urination, wipe front to back, no douching - 3 days of nitrofurantoin or trimethoprim - 7 day course for men - In pyelonephritis: ciprofloxacin 7-10 days - Topical oestrogen can decrease recurrence in post-menopausal women - If recurrent infections can use prophylactic antibiotics - TRIMETHOPRIM (if related to sex, within 2 hours of intercourse, or 6 months low dose) - Paracetamol or NSAIDs for symptom relief
391
Complications from UTIs
``` Pyelonephritis Perinephritic abscess Intrarenal abscess AKI Hydronephrosis Pyonephrosis Sepsis Prostatits Prostatic abscess ```
392
Pyelonephritis
TRIAD: LOIN PAIN, FEVER, TENDERNESS OVER KIDNEYS - Can be caused by the same organisms that ascend - Can be associated with papillary necrosis causing obstruction and AKI - More common in: chronic urinary obstruction, diabetics, sickle cell and analgesic nephropathy - Emphysematous pyelonephritis: necrotising producing gas - Xanthogranuloamtous pyelonephritis: chronic infection that resembles renal cancer causing obstruction
393
Diagnostic criteria for patients with diabetic symptoms
Symptoms plus one of: - Random glucose conc >11.1 - Fasting glucose > 7 - 2 hour glucose concentration after 75g of glucose (OGTT) >11.1
394
Diagnostic criteria for patients withOUT diabetic symptoms
Diagnosis should not be based on single glucose measurement Requires confirmatory plasma venous concentration At least one additional test on another day with a value in diabetic range 2 positive tests on 2 different days - random glucose>11/1 - Fasting glucose >7 - 2 hour OGTT >11.1
395
Role of HbA1c in diagnosing diabetes
Can be used to diagnose HbA1c >48mmol or 6.5% Cannot use in: - Children - If suspecting type 1 diabetes - <2 months of symptoms - High risk patients who are currently ill - Taking medications that can rapidly increasing glucose (steroids, antipsychotics) - Patients with acute pancreatic damage - Pregnancy
396
Define type 1 diabetes
body failure to produce sufficient insulin | Characterised by deranged metabolism and vascular sequale
397
Epidemiology of type 1 diabetes
``` 15% of diabetes 40% concordance in identical twins Increased in Caucasians, particularly Scandinavia Increased in women Incidence increasing ```
398
Aetiology and pathophysiology of type 1 diabetes
Can be split into 2 types: 1A proven autoimmune aetiology and IB no autoimmune component - T cell mediated autoimmune disease involving destruction of insulin secreting beta cells in islets of langerhan's - Progressive loss of beta cells takes months-years - Symptoms when loss of 80-90% functional loss - Damage beta cell specific - Autoantibodies can be found in blood prior to diagnosis - It is associated with other autoimmune diseases: thyroid disease, coeliac, Addison's, pernicious anaemia, vitiligo - Genetic: HLA DR3 or DR4 - Autoantibodies: anti-glutamic acid decarboxylase (GAD), islet cell and islet antigen 2 antibodies - Some thoughts about environmental factors
399
Diseases associated with type 1 diabetes
``` Thyroid disease Pernicious anaemia Vitiligo Coeliac disease Addison's disease ```
400
Genes associated with type 1 diabetes
HLA DR3 or DR4
401
Presentation of type 1 diabetes
Hyperglycaemia with one or more of: - Ketosis - Rapid weight loss - Under 50 - BMI <25 - Personal or family history of autoimmune disease Usually in childhood and early adult life Abrupt onset of symptoms Prone to ketoacidosis - Polyuria - Polydipsia - Lethargy - Increased thirst - Extreme hunger - Weight loss - Boils - Frequent and prolonged infection - Increased blood glucose, - Glycosuria - DKA
402
Investigations for type 1 diabetes
- Fasting blood glucose >7.0 - Random blood glucose >11.1 - Raised plasma or urine ketones - Can do antibody screen for: GAD (anti-glutamic acid decarboxylase), islet cell antibodies, islet cell antigen 2 antibodies
403
Management of type 1 diabetes
Early care plan - Diabetic education - Management of CV risk factors - Guidance on insulin - Support and indivualised care - Carbohydrate counting training - Advice on weight control and CV risk management - Increase exercise - Self monitoring at least 4 times per day (before each meal and before bed) - Aim fasting glucose 5-7 - Increase if many hypos, during illness, before, after or during sport, planning pregnancy, not achieving target - Regular follow up. HbA1c every 3-6 months - Inform patients of values at each consultation, aiming for HBa1c of 48 Insulin therapy - twice daily long acting INSULIN DETERMIR - Additional rapid acting insulin BEFORE meals - Teach injection technique, avoid repeating injection sites - Consider islet or pancreas transplant if recurrent severe hypoglycaemia not responding to treatments - Assess awareness of hypoglycaemia (using Gold or Clarke score) - If impaired awareness consider insulin pump (continuous subcut insulin infusion) Manage renal disease - Start ACEi - Maintain BP <130/80
404
Diagnostic criteria for DKA
All 3 of: - Blood glucose >11 (or known diabetic) - Blood ketones > 3 or urine ketones +++ - Bicarbonate <15 or ph<7.3
405
Epidemiology of DKA
4% of type 1 diabetics each year Normally only seen in T1DM Increased in under 45s 10% new diabetics, 15% interruption of insulin therapy, 30% intercurrent illness
406
Precipitating conditions for DKA
``` Infection Discontinuation of insulin Pregnancy Surgery Trauma Inadequate insulin CV disease e.g. stroke or MI Drugs - thiazides, steroids, SGLT2 inhibitors ```
407
Pathophysiology of DKA
State of uncontrolled catabolism associated with insulin deficiency Insulin deficiency leads to lipolysis, increase breakdown of free fatty acids, ketone build up, causes acidosis Hyperglycaemia causes glycosuria, leading to electrolyte losses and dehydration - renal failure Free fatty acids would normally enter Kreb's cycle In DKA, body not utilising glucose and so glucagon is released to cause gluconeogenesis and glycogenolysis This further increases blood sugar As gluconeogenesis is taking place, shortage of oxaloacetate leading to ketones not entering Kreb cycle Acidosis from raised ketones
408
Presentation of DKA
``` Usually develops within 24 hours Polyuria Polydipsia Nausea and vomiting Dehydration Blurred vision Weight loss Abdominal pain Leg cramps Weakness Altered mental state ``` ``` Kussmaul breathing Acetone smell on breath Hypothermia Reduced GCS Dehydration - dry mucous membranes, sunken eyes, long cap refill Tachycardia Hypotension ```
409
Investigations for DKA
Capillary blood glucose and plasma glucose (++) Urine dipstick - glycosuria and ketonuria Urine for microscopy and culture Assay of blood ketones Bloods - glucose (++), FBC (can have raised WCC), U&Es ABG - metabolic acidosis (raised anion gap) Screening for suspected causes - Troponins, ECG - CK - Amylase - CXR, AXR - Blood cultures, - LP - CT/MRI Plasma osmolarity - raised in DKA
410
Calculating plasma osmolarity
``` 2 x (Na + K) + urea + glucose Raised in DKA Very raised in HONK ```
411
Management of DKA
Immediate resuscitation Cannula and catheter 1. Fluid administration 2. Insulin therapy - IV insulin infusion (don't stop long acting insulin), continue until pH normal or ketones normal 3. Aim for ketones <0.5mmol/hr decrease Aim for glucose drop by 3mmol/hr 4. IV glucose when glucose <12 with 5% dextrose 5. Replace lost K+ to prevent hypokalaemia 6. Regular monitoring Post event management - review usual glycaemic control - review injection technique - assess need for handheld ketone monitors at home - education
412
Complications of DKA
Cerebral oedema - More common in children than adults - headache, behavioural changes, urinary incontinence Pulmonary oedema - Rare, usually within a few hours of treatment Iatrogenic hypoglycaemia Iatrogenic hypokalaemia VTE Hypophosphataemia ARDS
413
Prognosis for DKA
mortality <2% Prognosis worse in elderly and increased severity of precipitant Main cause of death in children is cerebral oedema
414
Analogue insulin
Lab grown in E.coli Genetically recombinant DNA technology More rapid and uniform
415
Rapid acting insulins (analogue)
Insulin aspart = Novorapid Insulin glulisine = Apidra Insulin lispro = Humalog
416
Long acting insulins (analogue)
Insulin detemir = Levemir Insulin glargine = Lantus Insulin degludec = Tresiba
417
Short acting human insulin
Humulin S Actrapid Takes 30 minutes after injecting Peaks at 2-3 hours
418
Humalog 30
Insulin lispro | 30% short acting, 70% long acting
419
Insulin delivery systems
Direct SC injections - abdomen, upper arm, buttock, outer thigh More injection site every 1-2 weeks Continuous SC insulin infusion therapy / insulin pump - Hard to access and expensive - Continuously delivers rapid acting via needle under skin to decrease number of injections Injection ports - alternative to daily injection, port connected to needle under skin, can remain in place for a few days Insulin pens - one shot devices. dial to adjust dose
420
Diagnosing Hypoglycaemia
Rests of 3 criteria: Whipple's triad - Plasma hypoglycaemia (<3) - Symptoms attributable to decreased blood sugar level - Resolution of symptoms with correction
421
Risk factors for hypoglycaemia
``` Tight glycaemic control Malabsorption Alcohol Injection in lipohypertrophy site Insulin prep error Long duration of diabetes Renal dialysis Drug interactions - SSRIs Decreased renal function Addison's Hypothyroid ```
422
Aetiology of hypoglycaemia
- Alcohol is most common non-iatrogenic cause - diabetes treated with insulin or sulphonyureas - Ketotic hypoglycaemia - Drugs and toxins - quinines, Paracetamol - Pancreatic insulinomas - Starvation - Self inflicted
423
Presentation of hypoglycaemia
``` Shaking/trembling Sweating Pins and needles in lips and tongue Hunger Palpitations Headache Double vision Confusion Difficulty concentrating Slurred speech Stupor/Coma ```
424
Investigations in hypoglycaemia
- Blood glucose - LFTs, TFTs - if ? insulinoma, 72 hour fast
425
Management of hypoglycaemia
Oral glucose/hypostop/glucogel - Repeat CBG after 15 minutes - If unconscious IV 75ml of 20% glucose - If pre-hospital and unconscious IM glucagon - If caused by oral antihyperglycaemics, admit for effects - If prolonged and associated cerebral oedema then IV mannitol, dexamethasone and glucose
426
Epidemiology of type 2 diabetes
``` Very common 4-6% 85% of diabetes Increases with age More common in South Asian and Blacks FHx associated ``` RFs - Obesity - Decreased exercise - Hyperlipidaemia - HTN - Smoking
427
Aetiology & pathophysiology of type 2 diabetes
50% identical twin concordance - strong inherited component - Poor nutrition in early life - Sub clinical inflammatory changes - Insulin resistance and beta cell dysfunction Cause of insulin resistance unknown Theory = central adipose tissue is metabolically active and releases large quantities of FFS and induce insulin resistance Pancreatic beta cell failure - amyloid deposition - raised glucose levels are toxic to beta cells
428
presentation of type 2 diabetes
``` Polyuria and nocturia Thirst Weight loss Blurred vision Low energy Nausea Headache Hyperphagia Mood change Irritability Difficulty concentrating Itchy vulva ``` Can present with complications
429
Investigations for type 2 diabetes
Diagnosed with usual blood testing - Fasting >7 - Random >11.1 - HbA1c > 48 Screen for complications at time of diagnosis Urine dip: positive glucose, negative ketones
430
Management of type 2 diabetes
- Patient education - Dietary advice - Encourage weight loss - Increase physical activity - BP management - Glucose control 1. Metformin, gradually increase dose over weeks to decrease GI symptoms 2. If HbA1c over 58 Consider: DDP-4i, pioglitazone, sulfonylurea, SGLT2i 3. If still over 58, add another. Triple therapy 4. Insulin
431
Dietary advice in type 2 diabetes
Low sugar diet Increase low glycaemic index carbohydrates Increase fibre Low fat Low salt Alcohol in moderation Regular meals, 3 times a day, avoid skipping
432
HbA1c targets in type 2 diabetes
Measure 3-6 monthly until stable then 6 monthly Target 48mmol/L if managed with diet and exercise Target 53 mmol/L if managed with oral medications
433
Complications of type 2 diabetes
``` gastroparesis Autonomic neuropathy Erectile dysfunction Retinopathy Neuropathy Nephropathy Increased CV risk ```
434
Microvascular complications of diabetes
``` Retinopathy, blindness Nephropathy Peripheral neuropathy - ulcers, difficulty walking Autonomic neuropathy Foot disease ```
435
Macrovascular complications of diabetes
Coronary circulation - MI Cerebral circulation - Stroke Peripheral circulation - claudication/ischaemia
436
DCCT trial
Diabetes control and complications trial - Study of type 1 diabetes - Lasted 9 years - If strict glycaemic control (rather than conventional) then decreased complications - High rates of severe hypoglycaemia
437
UKPDS study
UK Prospective Diabetes Study - Study of type 2 diabetes - Decreased complications and slower progression with good glycaemic control
438
ACCORD study
Action to Control Cardiovascular Risk in Diabetes - Increased mortality in aggressively lowered HbA1c - Not beneficial in older patients or those in long disease course - ACEi decreased complications
439
Diabetic retinopathy
One of the most common causes of blindness in 30-65 years Risk increases with duration of diabetes Present in almost all after 20 years
440
Risk factors for diabetic retinopathy
``` Increased duration of diabetes Poor glycaemic control Pregnancy Hyperlipidaemia Hypertension Obesity Smoking Nephropathy ```
441
Pathophysiology of diabetic retinopathy
Hyperglycaemia increases retinal blood flow and disrupts intracellular metabolism in retinal endothelial cells and pericytes Impaired vascular auto regulation, increased production of vasoactive substances and endothelial proliferation Results in capillary hypoperfusion and closure Chronic retinal hypoperfusion Increased VEGF Increased vascular permeability and new vessel formation
442
Stages of diabetic retinopathy
1. Non-proliferative Microaneurysm, dot and blot haemorrhages (retinal haemorrhages) 2. Pre-proliferative Cotton wool spots, venous beading, inter-retinal vascular abnormalities 3. Proliferative Growth of new vessels on retina/optic disc New vessels bleed causing vitreous haemorrhage and fibrosis Retinal detachment At any stage can develop clinically significant macular oedema which increases vascular permeability and deposition of hard exudates in central retina
443
Prevention of diabetic retinopathy
``` Good glycaemic control When glucose lowered - it can cause hyperglycaemia induced hyperperfusion Control BP <130/80 Screen annually Digital photography symptoms Refer to ophthalmology ```
444
Management of diabetic retinopathy
Ranibizumab - monoclonal antibody for VEGF-A used in macular oedema Retinal photocoagulation - in severe proliferation - Destroys areas of retinal ischaemia - Treat leaking micro aneurysm - Decreases risk of recurrent haemorrhage Usually argon laser under topical anaesthesia
445
Risk factors for diabetic nephropathy
``` Poor glycaemic control Increased duration of diabetes South Asians HTN FHx of HTN FHx of nephropathy Presence of other microvascular complications ```
446
Pathophysiology of diabetic nephropathy
Thickening of GBM and accumulation of matric material in mesangium - Microalbuminuria - Characteristic nodular deposits - Glomerulosclerosis worsens as heavy proteinuria develops - Glomeruli progressively lost and decreased renal function
447
Screening for diabetic nephropathy
Type 1 - annually 5 years after diagnosis Type 2 - annually from diagnosis early morning mid stream urine for albumin creatinine ratio - microalbuminuria is not detected on dipstick In overt nephropathy - macroalbminuria
448
Management of diabetic nephropathy
Prompt vigorous attempt to decrease risk of progression - Decreased BP - Start ACEi - Decreased constriction of efferent, which decreases hyperfiltration and decreased protein leak RRT can be beneficial earlier in diabetics Renal transplant changes lives, recurrence is slow
449
Diabetic neuropathy
Affects 50-90% of diabetics Increases morbidity and mortality Axonal degeneration of myelinated and unmyelinated nerves Thickening of Schwann cells basal lamina
450
Symmetrical sensory polyneuropathy in diabetes
``` Decreased vibration perception Glove and stocking pattern Reflex loss in lower limbs Feet paraesthesia Burning soles Wide based gait Weakness and atrophy in muscles Slower sensory and motor conduction Increased pressure on plantar aspects of metatarsal heads ```
451
Asymmetrical motor neuropathy in diabetes
``` Wasting of proximal leg muscles Weight loss Severe anterior leg pain Decreased reflexes Hyperaesthesia and paraesthesia Due to infarction of lower motor neurons of lumbrosacral plexus ```
452
Mononeuropathy in diabetes
``` Motor or sensory dysfunction in single cranial/peripheral nerve Severe rapid onset 3rd and 6th cranial nerve most common Femoral or sciatic nerve most common Median nerve compression - carpal tunnel Due to thickened connective tissue ```
453
Autonomic neuropathy in diabetes
``` Parasympathetic or sympathetic Postural hypotension Fixed HR Tachycardia Gastroparesis Dysphagia Nausea and vomiting Sweating Erectile dysfunction Nocturnal incontinence Oedema Delayed light reflexes ```
454
Foot ulcers in diabetes
Occurs due to trauma, neuropathy or peripheral vascular disease Ulcers develop at site of plaque, necrosis underneath, breaks surface
455
Charcot neuro-arthropahy
``` Progressive condition affecting the feet Early inflammation Joint dislocation Pathological fractures Deformity ```
456
Diabetic foot care
Low risk = foot care advice Moderate risk = refer to foot protection services, reassess 3-6 monthly High risk = refer to services, reassess 1-2 monthly ``` Podiatrist led. Give advice - Daily inspect and wash feet, change socks - Cut and file nails regularly - wear suitable well fitting shoes - check footwear for foreign bodies - cover cuts with dressings - do not burst blisters - stress importance of foot care ```
457
Management of diabetic ulcers
Document severity using SINBAD Site Ischaemia Neuropathy Bacterial infection Area Depth - Offloading - Control of infection/ischaemia - Wound debridement - Wound dressings - Foot x-ray if ?osteomyelitis - Treat infections with antibiotics
458
Production of thyroid hormones
1. Thyroglobulin synthesised and secreted into colloid 2. Inorganic iodine actively transported into follicular cell "trapping" via Na/I symporter 3. Iodine transported onto colloidal surface via pendrin and organified by THYROID PEROXIDASE ENZYME. It is incorporated into amino acid TYROSINE on surface of thyroglobulin to form MIT and DIT 4. Iodinated tyrosines couple to form T3 and T4 5. Tg is endocytosed 6. Tg is cleaved by proteolysis to free iodinated tyrosine and thyroid hormones 7. Iodinated tyrosine dehalogenated to recycle iodine 8. T4 converted to T3 in tissues
459
Control of thyroid hormone production
Hypothalamus - releases thyroid releasing hormone - TRH This stimulates the pituitary gland Pituitary gland releases thyroid stimulating hormone - TSH This stimulates thyroid gland to produce T4 and T3 In peripheral tissues T4 converted to T3 This has negative feedback on hypothalamus and pituitary gland
460
Epidemiology of hyperthyroidism
``` More common in women Highest in 40-60 group Increased in Caucasians and Asians More common in women Thyrotoxicosis 1/2000 ``` RFs - FHx - High iodine intake - Smoking - Trauma to thyroid gland - Toxic multinodular goitre - Child birth - HAART - HLA CTLA4 (grave's)
461
Aetiology of hyperthyroidism
``` 75% GRAVE's DISEASE 14% Toxic nodular goitre 5% solitary thyroid adenoma Thyroiditis 3% De Quervain's thyroiditis 1% Drug induced 0.1% Follicular carcinoma ``` Factitious (excessive levothyroxine) ``` 2Y causes: TSH secreting pituitary adenoma Thyroid hormone resistance syndrome hCG secreting tumour Gestational thyrotoxicosis ```
462
Graves disease
Most common cause of hyperthyroidism Autoimmune disease mediated by antibodies that stimulate the TSH receptor. Leading to excess secretion of thyroid hormones and hyperplasia of follicular cells Diffuse goitre
463
De Quervain's thyroiditis
Transient hyperthyroidism resulting from a viral infection Presents with features of hyperthyroidism with pyrexia and neck pain Often after an infection with Coxsackie, mumps or adenovirus Initially hyperthyroidism then hypo Painful thyroid, radiating to the jaw and ear, worse with swallowing and movement Usually in 20-40 years old Damage to fascicular cells causing release of stored thyroid hormones and impaired synthesis of new.
464
Drug induced hyperthyroidism
AMIODARONE Contrast agents Lithium Exogenous iodine - Should check TFTs prior to starting Amiodarone. - Can cause hypo or hyperthyroidism - in 6-10% of people on Amiodarone, more common in iodine deficient areas Type 1 - thyrotoxicosis in patient with thyroid disease Type 2 - thyrotoxicosis from destructive thyroiditis without underlying disease STOP drug
465
Factitious thyrotoxicosis
Consuming excessive amounts of levothyroxine It the suppresses TSH secretion and iodine uptake, serum thyroglobulin and release of endogenous thyroid hormones T4:T3 ratio is 70:1 Usually in thyrotoxicosis 30:1
466
Subclinical hyperthyroidism
``` Low TSH Normal T3 and T4 2% of elderly Look for signs of low TSH and normal T3/T4 - glucocorticoids, dopaminergic drugs, Amiodarone Recheck TFTs regularly Most common cause = toxic nodular goitre ```
467
Presentation of hyperthyroidism - Symptoms
``` Weight loss with increased appetite Irritability Weakness and fatigue Diarrhoea +/- steatorrhoea Sweating Tremor Mental illness Heat intolerance Loss of libido Oligomenorrheoa, amenorrhoea ```
468
Presentation of hyperthyroidism - Signs
``` Palmar erythema Fine tremor Hyper-reflexia Tachycardia Hair thinning or diffuse alopecia Urticaria Goitre Proximal myopathy Gyanecomastia Lid lag Thyrotoxic periodic paralysis ```
469
Signs of Grave's disease
``` Exophthalmos Opthalmoplegia Conjunctival oedema Papilloedema Pretibial myxoedema Clubbing Splenomegaly ```
470
Thyroxtoxic storm
1-2% patients with hyperthyroidism Hyperthermia + mental disturbance + thyrotoxic symptoms Assocaited with precipitating events: withdrawal of anti-thyroid drug, radioiodine therapy, infection, surgery Manage with IV fluids, Beta blockers, anti thyroid drugs, steroids 20-30% mortality due to arrhythmias and hypothermia
471
Investigations for hyperthyroidism
TFTs - High T4 (mainly) and T3 (5% have T3 thyrotoxicosis) - Low TSH Autoantibodies (GRAVES) - thyroid peroxidase antibodies - antithyroglobulin antibodies - TSH receptor antibodies ** Bloods - AST, GGT and ALP raised - mild hypercalcaemia Thyroid US scan CRP and ESR raised in thyroiditis ECG for sinus tachy or AF
472
TFTs in: | Primary thyrotoxicosis
Raised T3 Raised T4 Undetectable TSH
473
TFTs in: | Primary T3 thyrotoxicosis
Raised T3 Normal T4 Undetectable TSH
474
TFTs in: | Subclinical thyrotoxicosis
Normal T3 Normal T4 Low TSH
475
TFTs in: | Secondary thyrotoxicosis
Raised T3 Raised T4 Raised TSH
476
Management of hyperthyroidism
Beta blockers (propranolol) for symptom control Carbimazole or propylthiouracil - Inhibit production of thyroid hormones - Takes 2-3 weeks to work - 1st line: carbimazole - Use propylthiouracil in pregnancy or thyroid storm - Block and replace with levothyroxine - Repeat TFTs every month and adjust dose according to T4 level - Remission achieved after 18-24 months and can attempt to stop drugs - IF THEY DEVELOP SORE THROAT = FBC = BONE MARROW SUPPRESSION Can use radioactive iodine - 1st choice = teenagers, relapsed Grave's, toxic nodular hyperthyroidism Surgery - Infrequently used - Euthyroid state prior to surgery to avoid thyroid storm - Subtotal or near total thyroidectomy has 98% cure rate
477
Radioactive iodine
Radioactive iodine taken up by thyroid and destroys the gland - Inexpensive and definitive - Must stop antithyroid drugs for 5-7 days before - not in pregnancy, breastfeeding or planning to get pregnant in next 6 months - Avoid close contact with children and pregnant women
478
Complications from thyroid surgery
Haemorrhage Hypoparathyroidism Vocal cord paralysis
479
Multinodular goitre
Nodules secrete thyroid hormone autonomously and suppressing TSH dependent growth If very large = retrosternal Mediastinal compression, stridor, dysphagia, SVCO
480
Acromegaly
Growth hormone stimulates production of insulin like growth factor (IGF-1) IGF-1 is the main mediator of the action of growth factor. Acromegaly is caused by excessive secretion of growth hormone by pituitary tumour Overgrowth of all organ systems, bones, joints and soft tissues,
481
Epidemiology of acromegaly
1 per 250,000 Most commonly diagnosed in 40s Equal in men and women Often diagnosed 10 years after onset due to insidious onset and slow progression
482
Presentation of acromegaly
Headaches Visual defect: bilateral hemianopia Gradual change in appearance due to effects on cartilage and soft tissues - Enlargement of hands and feet - Frontal bossing - Thickening of nose - Enlarged tongue (macroglossia) - Growth of jaw - Coarsening of facial features ``` Excessive sweating Development of skin tags Thickened skin Some have sleep apnoea from enlarged tongue Women have mild hirsuitism Widespead osteoarthritis Visceral hypertrophy Carpal tunnel syndrome HTN, LVH, cardiomyopathy ``` Galactorrhoea, amenorrhoea
483
Investigations for acromegaly
Visual field tests - Random GH - often not diagnostic - Glucose tolerance test: GH normally inhibited by glucose. If glucose fails to suppress GH level and IGF1 is raised then diagnose acromegaly Assess other pituitary hormones; prolactin, thyroid, FSH, LH MRI of pituitary and hypothalamus CT for lung, pancreatic, adrenal or ovarian tumours that secrete GH Cardiac assessment: ECG, echo Screen for bowel cancer - increased prevalence in acromegaly
484
Management of acromegaly
Somatostatin analoge - OCTREOTIDE Dopamine agonists - bromocriptine, cabergoline - Increases risk of fibrosis - tumours that secrete GH and prolactin will have better response to dopamine agonists Pegvisomant - Highly selective GH receptor antagonist. Used as 2nd line Trans-sphenoidal surgery is treatment of choice Patients with residual disease can be offered adjunct treatment Radiotherapy is used in refractory disease or when surgery contraindicated.
485
Complications of acromegaly
``` HTN, IHD, HD, cerebrovascular disease Diabetes Acromegalic arthropathy Obstructive sleep apnoea Increased colon cancer and polyps Hypopituitarism post op ``` Increased mortality Better prognosis with smaller tumour
486
Define Cushing's syndrome
Excessive activation of glucocorticoid receptors Most commonly iatrogenic due to excessive glucocorticoid treatment Endogenous rare - excessive ATCH from pituitary tumour to ectopic ACTH by other tumours
487
Epidemiology of Cushing's syndrome
10 per million Higher incidence in diabetes, obesity, hypertension, osteoporosis If due to tumour: more common in women (5:1) Peak incidence for tumour is 25-40 years Ectopic ACTH production due to lung cancer occurs late in life
488
Aetiology of Cushing's syndrome
Exogenous glucocorticoids Endogenous - Corticotropin-dependent causes (80-85%) 80% pituitary adenoma 20% are due to ectopic corticotropin syndrome from small cell lung cancer (other endocrine tumours: phaeochromocytoma, medually thyroid) - Corticotropin independent causes 60% adrenal adenoma 40% adrenal carcinoma RARE: macronodular adrenal hyperplasia, primary pigmented nodular adrenal disease, McCune-Albright syndrome Pseudo-Cushing's - Alcohol excess - Major depressive illness - Primary obesity
489
Presentation of Cushing's syndrome
``` Hypertension Central obesity Buffalo hump Weight gain Thin skin Striae Wasting and weakness of proximal thighs Bruising Poor wound healing Osteoporosis Fractures Hyperglycaemia Peptic ulcer Moon face Thinning hair Hirsutism Cataracts Psychosis Gondal dysfunction or reduced libido ```
490
Investigations for Cushing's disease
Testing should not be done in times of stress - acute illness activates HPA axic 1. Establish whether the patient has Cushing's - 24 hour urinary free cortisol ideally 3 collections, cortisol should be >3x upper limit on 2+ tests - 1mg overnight dexamethasone suppression test At 11pm given 1mg dex, measure serum cortisol at 8am - Late night salivary cortisol - FBC: raised WCC - U&Es: hypokalaemia - Metabolic alkalosis 2. Determine the cause - Plasma ACTH (highest at 8am, lowest at midnight) diurnal pattern - Undetectable ACTH + increased cortisol = ACTH independent Cushing's - High ACTH = ACTH dependent cushing's If ACTH undetectable - High dose dexamethasone suppression test - Inferior petrosal sinus sampling - MRI of pituitary - Chest and abdo CT - Plasma corticotropin releasing hormone
491
Management of Cushing's syndrome
Tumour resection Medical therapy: - Prepping for surgery - Unfit for surgery - Persistent raised cortisol post-op - Metyrapone, ketoconazole, mitotane - inhibits synthesis and secretion in adrenal gland - not effective long term. Surgery: - trans-sphenoidal surgery - surgical removal of tumours or ectopics
492
Complications of Cushing's disease
``` Metabolic syndrome Hypertension Impaired glucose tolerance and diabetes Obesity Hyperlipidaemia Coagulopathy: thrombophilia Osteoporosis perforated viscera Nelson's syndrome Impaired immunity Opportunistic infections ``` 5x mortality risk
493
Anatomy of adrenal gland
Has medulla and cortex Cortex is split into: - Zona glomerulosa (releases aldosterone) - Zone fasciculata and reticularis (releases cortisol and androgens)
494
Cortisol
Released from zona fasciculata and reticularis Levels are highest in the morning on waking and lowest in the middle of the night Rapidly rises with stress and illness 95% is protein bound - principally cortisol binding globulin which is increased by oestrogens It is the free 5% that is biologically active - Regulates the cell function by binding to glucocorticoid receptors that regulate the transcription of genes - Can activate mineralocorticoid receptors, - They do not do it normally as mineralocorticoid receptors as they contain an enzyme (11beta HSD2) that inactivates cortisol by converting to cortisone - 11 beta HSD2 inhibitors is in liquorice which causes hypertension, sodium and water retention.
495
Mineralocorticoids
Aldosterone is most important binds to mineralocorticoid receptors in the kidney and causes sodium retention Increased excretion of K+ and H+ Principal stimulus to aldosterone is angiotensin II
496
Catecholamines
NA, adrenaline Only a small proportion is derived from adrenal medulla - the rest for sumpathetic nerve endings Conversion of NA to adrenaline is catalysed by catechol-o-methyltransferase (COMT) which is induced by glucocorticoids Blood flow in adrenals is centripetal so medulla is bathed in high concentrations of cortisol and is the major source of circulating adrenaline
497
Define hypothyroidism
Insidious onset Significant morbidity Often wrongly attributed to other illnesses particularly in post-partum and elderly Initially increase in TSH with normal T3 and T4 Then decrease T4 causing symptoms
498
Epidemiology of hypothyroidism
More common in women Overt 2% women, 0.2% men Subclinical 7% women, 3% men 2.5% of pregnant women - Risk increases with age, most common in 60s - Autoimmune thyroiditis more common in Japan
499
Aetiology of hypothyroidism
Insufficient secretion of thyroid hormones - PRIMARY - Autoimmune: Hashimoto's thyroiditis - Iatrogenic: radioiodine treatment, surgery, radiotherapy - Iodine deficiency (most common worldwide) goitre present - Drugs: Amiodarone, contrast media, iodide, lithium, anti thyroid medication - Iodine: very high concentrations - Congenital defects: absence of thyroid cells - Infiltration of thyroid: amyloidosis, sarcoidosis, hemochromatosis
500
Hashimoto's thyroiditis
``` Autoimmune Associated with goitre Painless goitre Rubbery consistency Irregular surface Increased risk of thyroid lymphoma Positive thyroid peroxidase antibodies In under 20s - can be antinuclear factor positive ```
501
Atrophic thyroiditis
Spectrum of hypothyroidism end stage of autoimmune hypothyroidism Patients are overtly hypothyroid
502
Amiodarone and thyroid disease
The structure is analogous to T4 and contains a huge amount of iodine Thyrotoxic on thyroid follicular cells and inhibits conversion of T3 to T4
503
Secondary hypothyroidism causes
Isolated TSH deficiency Hypopituitarism - cancer, infiltrative, infection, radiotherapy Hypothalamic disorders - cancer or trauma
504
Transient hypothyroidism causes
- Withdrawal of thyroid suppressive therapy - Postpartum thyroiditis 5-7% of pregnancies in the first 6 months - Subacute/chronic thyroiditis with transient hypothyroidism - De Quervain's thyroiditis - initially hyperthyroid then become hypo
505
Presentation of hypothyroidism
Insidious onset ``` Tiredness, lethargy, fatigue Low mood Dry skin, hair loss Slowing of intellectual activity, poor memory, difficulty concentrating Constipation Decreased appetite with weight gain Deep hoarse voice Menorrhagia Impaired fluid due to fluid in middle ear Reduced libido Depression ```
506
Signs of hypothyroidism
``` Dry coarse skin Hair loss Cold peripheries Myxoedema (puffy face, hands and feet) Bradycardia Delayed tendon reflex Carpal tunnel syndrome Pallor Effusions - pericarditis, pleural effusions ``` AKI Female sexual dysfunction Hypercholesterolaemia
507
Myxoedema
Expressionless dull face with periorbital puffiness, swollen tongue, sparse hair Pale, cool skin with rough doughy texture Enlarged hart Megacolon, intestinal obstruction Cerebellar ataxia Psychosis Encephalopathy
508
TFTs in: | Primary hypothyroidism
Low T3 Low T4 Raised TSH
509
TFTs in: | Subclinical hypothyroidism
Normal T3 Normal T4 Raised TSH
510
TFTs in: | Secondary hypothyroidism
Low T3 Low T4 Low TSH
511
Investigations in hypothyroidism
TFTs Anti-thyroid peroxidase antibodies (anti-TPO) Or antithyroglobulin antibodies Antibodies are found in 95% of autoimmune thyroiditis Anaemia FBCs, U&Es, LFTs US if asymmetrical goitre to rule out cancer.
512
Management of clinical hypothyroidism
Levothyroxine (T4/tetraiodothyronine) - Initial dose of 50-100 mcg then adjusted up by 25-50mcg every 3-4 weeks depending on response - Start lower (50mcg, up by 25mcg) if over 50, severe hypothyroidism or cardiac disease Once stable check TSH annually. T3 therapy has risks - osteoporosis, cardiac arrhythmias. Symptom relief can take up to 6 months after TSH levels have normalised Drugs that can interfere with absorption - ferrous sulphate, calcium supplements, rifampicin, Amiodarone
513
Management of subclinical hypothyroidism
TSH high but normal T4 If TSH very high then may benefit from levothyroxine Treat patients if history of radio-iodine treatment or positive thyroid antibody test as they will always progress to overt.
514
Myxoedema coma
Seen in elderly Mortality of 20-50% Major precipitating factors: stop thyroid medication ro infection ``` Reduced level of consciousness Seizures Hypothermia Features of hypothyroidism Hypoventilation causing hypoxia and hypercapnia Hyponatraemia Hypoglycaemia ``` Treat with IV levothyroxine Supportive therapy - correct metabolic disturbances, warming if hypothermic May need to be intubated if severe hypoventilation IV hydrocortisone as impaired adrenal function if often present in profound hypothyroidism
515
Define Addisonian crisis
Potentially fatal and mainly associated with acute deficiency of cortisol and to a lesser extent aldosterone It occurs in long term adrenal insufficiency and 8%of people with Addison's disease will need annual hospital admission for crisis
516
Aetiology of Addisonian crisis
Occurs when physiological demand exceeds ability of adrenal glands to produce them Generally with intercurrent illness or stress ``` Major illness or infection - most commonly GI Injury Surgery Burns pregnancy GA MI Acute allergic reactions Acute hypoglycaemia in diabetics ``` Abrupt cessation of steroids Sudden loss of adrenal function in bilateral adrenal haemorrhage
517
Presentation of Addisonian crisis
``` Malaise Fatigue Nausea or vomiting Abdominal pain Low grade fever Muscle cramps and pains ``` ``` Followed by: Dehydration Hypotension Hypovolaemic shock Confusion Loss of consciousness Coma ```
518
Investigations in Addisonian Crisis
``` Low sodium, high potassium May have raised creatinine Hypoglycaemia Hypercalcaemia Cortisol and ACTH levels - treat before results Test for precipitating causes ```
519
Management of Addisonian Crisis
Urgent admission Start treatment ASAP without results Immediate IV or IM hydrocortisone - do not need to give fludrocortisone in acute Rehydration with normal saline Continuous cardiac and electrolyte monitoring After rehydration and hydrocortisone = 5% glucose Treat underlying disorder Gradually reduce steroid dose back to oral
520
Prevention of Addisonian crisis
Don't stop steroids suddenly Alter doses of steroids for illness or surgery Educate patients Medical emergency identification bracelet or similar steroid cards Educate treatment for crisis
521
Addison's disease
Adrenal insufficiency Destruction of adrenal cortex and subsequent reduction in amount of adrenal hormones - glucocorticoids - mineralocorticoids (aldosterone) ``` Primary insufficiency (Addison's disease) Inability of the adrenal glands to produce enough steroid hormones Most common cause is autoimmune disease ``` Secondary - inadequate pituitary of hypothalamic stimulation of adrenal glands
522
Epidemiology of Addison's disease
Primary is rare 1 in 10,000 Most common age is 30-50 years More common in women Secondary is more common More common in women peak in 50-60 years
523
Aetiology of primary adrenal insufficiency
``` Addison's disease (85%) autoimmune Surgical removal of adrenals Trauma Infections e,g, TB, histoplasmosis, HIV, syphilis Haemorrhage ``` Enzyme inhibition - ketoconazole, fluconazole Congential adrenal hyperplasia Accelerated hepatic metabolism of cortisol - phenytoin, barbituates, rifampicin ACTH or glucocorticoid resistance ACTH blocking antibodies Mutation in ACTH receptor gene Familial adrenal insufficiency
524
Aetiology of secondary adrenal insufficieny
Hypothalamic related - Congenital - CRH deficiency - Trauma (fracture of school base) - Radiotherapy/surgery - Cancer Suppression of HPA - Exogenous steroids - antipsychotics e.g. chlorpromazine - steroid production from tumours Pituitary - tumours - panhypopituitarism - Isolated ACTH deficiency
525
Triggers for adrenal insufficiency
``` Sepsis Severe pneumonia ARDS Trauma HIV infection ```
526
Symptoms of Addison's disease
Can present acute or chronic ``` Fatigue and weakness Anorexia Nausea and vomiting Weight loss Abdominal pain Diarrhoea/constipation Cravings for salty food or liquorice Muscle cramps and joint pain Confusion Syncope or dizzy Personality change Irritability Loss of pubic or axillary hair in women ```
527
Signs of Addison's disease
``` Hyperpigmentation - only in primary Buccal mucosa, lips, palmar creases, new scar, pressure areas Due to ACTH excess Hypotension Postural hypotension ```
528
Investigations for Addison's disease
Bloods - Low sodium - High potassium - Raised calcium - FBC: may be anaemia, mild eosinophilia, lymphocytosis - Hypoglycaemia - Reduced cortisol (get expert advice if shift worker, pregnant or taking oestrogen) - ACTH (high in primary, low in secondary) - Renin often high - Aldosterone low Synacthn test - measure cortisol levels after ACTH given. No rise in cortisol = adrenal insufficiency Adrenal antibodies - 2l-hydroxylase antibodies CXR - rule out lung cancer CT of adrenals if antibody negative
529
Diseases associated with Addison's disease
``` Thyroid disorders Diabetes mellitus Pernicious anaemia Vitiligo Premature ovarian failure 40-50% will develop an associated endocrine abnormality ```
530
Polyglandular autoimmune syndromes
Type 1 in children Type 2 in adults Type 1: adrenal insufficiency, hypoparathyroidism and chronic candidiasis Type 2: adrenal insufficiency, autoimmune thyroid disease,, +/- diabetes mellitus
531
Management of Addison's disease
Done by endocrinologist Medical emergency identification card patient education on not missing steroids - Glucocorticoid replacement - hydrocortisone - Highest dose in the morning but TDS - Increase dose in any illness (3x in minor, 10x in major) - Mineralocorticoid - fludrocortisone in primary insufficiency - Annual check
532
Complications of Addison's disease
``` Adrenal crisis Reduced quality of life Loss of libido Frequent admissions for crisis Osteoporosis Untreated can be fatal ```
533
Types of thyroid cancer
``` Papillary thyroid carcinoma (70%) Follicular thyroid carcinoma (10%) Medullary thyroid carcinoma (5-8%) Thyroid lymphomas (5%) Hurthle cell carcinoma (4%) Anaplastic thyroid carcinoma ```
534
Papillary thyroid cancer
Most common (70%) Presents between 35 and 40 years 3x more common in women Presents as micropapillary thyroid carcinoma <1cm with excellent prognosis Tends to spread locally to the neck, compressing the trachea and can involve recurrent laryngeal nerve Mets to lung and bone
535
Follicular thyroid cancer
``` 2nd most common (10%) Tends to occur in areas of low iodine 3x more common in women presents between 30 and 60 may infiltrate the neck as papillary cancer but has a greater propensity to metastasise to lung and bone ```
536
Medullary thyroid cancer
Arises from parafollicular calcitonin producing C cells 5-8% of thyroid cancers Female preponderance less marked Malignant C cells produce and secrete large amounts of peptides including: CEA, calcitonin, serotonin, ACTH and prostaglandins 75% occur sporadically 23% familial - part of MEN 2A or 2B Multiple endocrine neoplasia
537
Thyroid lymphomas
Almost always Non-Hodgkins Mainly women over 50 Associated with Hashimoto's thyroiditis Presents with rapidly growing mass in neck which can cause symptoms of obstruction - dysphagia or dyspnoea Occurs in 70-80% of those with hypothyroid
538
Hurthle cell carcinoma
3-10% 75-100% Hurthle cell components More common in females Most common 50-60 years Impossible to distinguish from benign using FNA - should be treated with surgical resection Behaves more aggressively than well differentiated cells High rate of mets and lower survival rate
539
Anaplastic thyroid carcinoma
``` Most aggress thyroid tumour One of the most aggressive human cancers Arises from follicular cells but does not retain any biological features Peaks in 60-70years develops from pre-existing well-differentiated thyroid cancer with additional mutations Hard mass Invading the neck causing compression 50% have mets at presentation mean survival is less than 6 months ```
540
Epidemiology of thyroid cancer
``` More common in women 1% of all cancer Rare in children peaks at 35-39 and again in 70s More common in Asians ``` RFs - Exposure to ionising radiation - Hisotry of goitre, thyroid nodule or thyroiditis - FHx of thyroid disease - Genetics: medullary cancers associated with mutations in RET proto-oncogene causing MEN2 - Cowden's syndrome - macroencephaly, LD, carpet pile tongue, breast disease - FAP - Obesity
541
Presentation of thyroid cancer
``` Presents as thyroid nodule Solitary nodule can be soft to hard Hard and fixed = malignancy Usually non-tender to palpation Vocal cord paralysis (recurrent laryngeal nerve) ```
542
Red flags for thyroid cancer
``` FHx of thyroid cancer Previous irradiation Child Unexplained hoarseness or stridor with goitre Painless thyroid mass, rapidly enlarging Palpable cervical lymphadenopathy ```
543
Investigations for thyroid cancer
TFTs - most will be euthyroid Serum calcitonin - for meduallary US - extremely sensitive for thyroid nodules. Hypogenicity, microcalcifications, absence of peripheral halo, irregular borders, solid aspect, increased blood flow, more tall than wide. FNA - on any nodule >1cm or <1cm if ?malignancy Radionuclide imaging to distinguish functioning toxic nodules and thyroid mets from follicular and papillary carcinomas. - Unreliable to confirm cancer - 4% of hot contain tumour, 16% cold CT and MRI to detect local and mediastinal spread
544
Management of thyroid cancer
Refer urgently Surgical removal - total thyroidectomy if >4cm, multifocal, mets - Recurrent laryngeal nerves are close and are at risk during surgery - lymph node removal Can use radio-iodine remnant ablation Radiotherapy if high risk of recurrence, local invasion at surgery or residual tumour If anaplastic - no treatment due to poor prognosis Most has good prognosis - 90% survival at 10 years With the exception of anaplastic - 5% at 5 years
545
Causes of intestinal obstruction
Small bowel - Adhesions - Strangulated hernia - Malignancy - Volvulus - Cancer - Paralytic ileus - Bowel surgery (post-op) - Congenital malformations - Hirschsprung's - Gallstone ileus - Severe constipation - Crohn's - Bezoar
546
Causes of paralytic ileus
Bowel ceases function and there is no peristalsis - Pneumonia - Acute MI - Trauma - Pueperuim - Stroke - Severe hypothyroidism - Electolyte disturbance - AKI - DKA
547
Presentation of bowel obstruction
``` Diffuse central colicky abdominal pain Vomiting (first in high level) Retrograde peristalsis can cause faeculent material to come up. Faster presentation in upper GI Abdominal distension Absolute constipation ``` ``` Dehydration Pyrexia if perforation or bowel infarction Massive peristalsis may be visible Distended bowel resonant to percussion Very active bowel sounds - TINKLING ```
548
X-ray finding in bowel obstruction
AXR - supine and erect - Ladder like series of small bowel loops - Fluid levels in upright views - Distended loops - Large bowel distension - Gas under diaphragm = perforation
549
Investigations in bowel obstruction
Fluid monitoring AXR FBC, U&Es, LFTs, cross match CT
550
Management of bowel obstruction
Uncomplicated = fluid resuscitation, electrolyte replacement, intestinal decompression, bowel rest Endoscopy for decompression - stents, dilate strictures if ischaemia, perforation or peritonitis - SURGERY
551
Haemochromatosis - Definition - presentation
Hereditary disease Autosomal recessive Excessive intestinal absorption of dietary iron resulting in pathological increase in total iron body stores Excess iron accumulates in tissues - Liver, adrenals, heart, skin, gonads, joints present with cirrhosis, polyarthropathy, adrenal insufficiency, heart failure or diabetes. - Fatigue - malaise - Joint and bone pain - Insulin resistance - Erectile dysfunction Most common in Northern Europeans
552
End organ damage of haemochromatosis
Liver cancer Cirrhosis Diabetes Congestive heart failure Arrhythmias Pigment changes: bronze or grey discolouration in skin due to increased melanin deposition
553
Blood tests in haemochromatosis
Free iron Transferrin Ferritin All high
554
Primary biliary cirrhosis
Also known as primary biliary cholangitis Autoimmune disease of the liver Slow, progressive destruction of the small bile ducts in the liver. Causes cholestasis, scarring, fibrosis then cirrhosis Symptoms: - Tiredness - itching - Jaundice Increased in females (x9)
555
Blood test for primary biliary cirrhosis
Anti mitochondrial antibody | Elevated ALP and GGT
556
Primary sclerosing cholangitis
Disease of the bile ducts that causes inflammation and obliterative fibrosis of bile ducts and liver Most commonly associated with IBD - mainly UC - Pruritus - Severe fatigue - Episodes of acute cholangitis - Dark urine - Malabsorption - Hepatomegaly IDIOPATHIC Beading on ERCP
557
Blood tests in primary sclerosing cholangitis
Raised ALP C 80% have anti-neutrophil cytoplasmic antibodies (not specific to PSC) ANA and anti-smooth muscles (neither are specific to PSC)
558
Causes of nephrotic syndrome in children
MINIMAL CHANGE Focal segmental
559
Causes of nephrotic syndrome in adults
Membranous glomerulonephritis Diabetic nephropathy SLE Amyloidosis
560
Secondary causes of membranous glomerulonephritis
Adenomas - bronchial Penacillamine Gold hepatitis B
561
Amyloidosis
Amyloid protein deposition in tissues. Primary AA amyloidosis AmyloidA-amyloidA Secondary AL amyloidosis amyloidA-light chains Seen in plasma cell dyscrasia or myeloma
562
Causes of raised amyloid A
Chronic inflammation - RA, Crohn's | Chronic infection - Bronchiectasis, osteomyelitis
563
Nephritic syndrome
Haematuria Hypertension AKI (Oedema)
564
P-ANCA
Perinuclear Anti Neutrophil Cytoplasmic Antibdoies - UC - Primary sclerosing cholangitis - RA - Microscopic polyangiitis - Focal necrotising and crescentic glomerulonephritis
565
C-ANCA
Granulomatosis with polyangiitis | Wegner's
566
Blood tests in ALE
Anti ds-DNA is highly specific | ANA - sensitive but not specific
567
ECG changes in hyperkalaemia
Tented t waves Broad QRD Lose p waves Sine wave
568
Define anion gap - high and low
Na + K+ - Cl - HCO3 High anion gap > 16 Low anion gap < 16
569
Causes of high anion gap
``` Ketoacidosis Uraemia Salicylic acid (aspirin) Methanol/ethylene glycol Alcohol Lactic acidosis ``` KUSMAL
570
Causes of metabolic acidosis with normal anion gap
Renal tubular acidosis | Diarrhoea
571
Drugs causing interstitial renal damage
Antibiotics (penicillin) PPIs NSAIDs
572
Causes of renal renal failure
Glomerular - causes of nephritic syndrome Interstitial - drugs Tubular - acute tubular necrosis Tubule obstruction - uric acid, myeloma, acyclovir, adanovir
573
Acute Tubular Necrosis
Occurs in renal ischaemia or nephrotoxins - tubular necrosis with sloughing of epithelial cells - Occlusion of tubular lumen by cellular debris
574
Granulomatosis with polyangiitis presentation
Wegner's ``` Rhinitis Rapidly progressive glomerulonephritis --> CKD Upper airway and ear disease - Oral ulcers - Purulent or bloody discharge Pulmonary nodules - coin lesions Haemoptysis Arthritis Skin - nodules on elbows, purpura ``` Rarely affects heart, GI tract and brain
575
Complications of endoscopy
``` Bleeding Infection Tearing of the GI tract Aspiration Reactions to sedative medications if given ```
576
Honeymoon period in diabetes
After first diagnosis (type 1) for the first few months to year there is a lower insulin requirement due to some insulin still being produced Make parents aware as otherwise control will go off for unknown reason
577
Antibodies positive in type 1 diabetes
GAD antibodies - glutamic acid decarboxylase autoantibodies | Islet cell antibodies